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During my PhD I worked on two main projects with the aim of unravelling psychiatric 
sub-phenotypes. These projects led to the following manuscripts (first authorship): 
(1) Cortical network dysfunction caused by a subtle defect of myelination 
Poggi G, Boretius S, Möbius W, Moschny N, Hassouna I, Ruhwedel T, 
Baudewig J, Nave KA, Ehrenreich H. Manuscript in preparation.  
Project: The focus of this project was to understand the role of myelin basic 
protein reduction in the context of psychiatric disease, specifically 
schizophrenia. This project is extensively described and discussed in this thesis. 
 
(2) Accumulated common variants in the broader fragile X gene family 
modulate autistic phenotypes 
Stepniak B, Kästner A, Poggi G, Mitjans M, Begemann M, Hartmann A, Van der 
Auwera S, Sananbenesi F, Krueger-Burg D, Matuszko G, Brosi C, Homuth G, 
Völzke H, Benseler F, Bagni C, Fischer U, Dityatev A, Grabe HJ, Rujescu D, 
Fischer A, Ehrenreich H.EMBO Molecular Medicine, in press 
Abstract: Fragile X syndrome (FXS) is mostly caused by a CGG-triplet-
expansion in the fragile X mental retardation 1 gene (FMR1). Up to 60% of 
affected males fulfill criteria for autism spectrum disorder (ASD), making FXS 
the most frequent monogenetic cause of syndromic ASD. It is unknown, 
however, whether normal variants (independent of mutations) in the fragile X 
gene family (FMR1, FXR1, FXR2) and in FMR2 modulate autistic features. 
Here, we report an accumulation model of 8 SNPs in these genes, associated 
with autistic traits in a discovery sample of male schizophrenic patients (N=692) 
and 3 independent replicate samples: Schizophrenia patients (N=626), patients 
with other psychiatric diagnoses (N=111) and a general population sample 
(N=2005). For first mechanistic insight, we contrasted microRNA expression in 
peripheral blood mononuclear cells of selected extreme group subjects with 
high- versus low-risk constellation regarding the accumulation model. Thereby, 
the brain-expressed miR-181 species emerged as potential 'umbrella regulator', 





conclude, normal variation in these genes contributes to the continuum of 
autistic phenotypes. 
I also contributed to other projects that led to the following publications (co-
authorship): 
(1) Gpm6b deficiency impairs sensorimotor gating and modulates the 
behavioral response to a 5-HT2A/C receptor agonist. 
Dere E, Winkler D, Ritter C, Ronnenberg A, Poggi G, Patzig J, Gernert M, 
Müller C, Nave KA. Behav Brain Res. 2015 Jan 15; 277:254-63 
(2) Fast cerebellar reflex circuitry requires synaptic vesicle priming by 
munc13-3. 
Netrakanti PR, Cooper BH, Dere E, Poggi G, Winkler D, Brose N, Ehrenreich 
H. Cerebellum. 2015 Jun; 14(3):264-83 
(3) The brain as immunoprecipitator of serum autoantibodies directed against 
the NMDAR subunit NR1  
Castillo-Gomez E, Kästner A, Steiner J, Weber F, Hettling B, Poggi G, Asif AR, 
Pfander V, Gámez Viana MA, Hammer C, Schulz T, Binder L, Stöcker W, 











Myelin, the proteolipidic layer that wraps around the axon, is one of the evolutionary 
advantages for animals with complex behaviour and reasoning.  Myelin ensures axonal 
support and synchronised electrical communication among different brain areas. During 
the last two decades several studies have consistently reported myelin abnormalities in 
schizophrenia. Myelin Basic Protein (MBP), one of the major myelin structural 
proteins, has become more and more appealing for the attempt of understanding the role 
of myelin abnormalities in neuropsychiatric diseases. Due to its essential role in the 
correct formation of the myelin sheath, we wondered whether a reduction in MBP could 
be detrimental for the brain connectivity and functionality, hence leading to the 
appearance of specific symptomatology reported in schizophrenia. We characterised a 
mouse line expressing only 50% of MBP, i.e. the heterozygous strain of shiverer mice 
(here referred as Mbp+/- mouse). Through the combination of several methods 
(behavioural testing, magnetic resonance imaging, spectroscopy histology, electron 
microscopy and biochemical analyses), we proved that, upon ageing,the prefrontal 
cortex and its underlying white matter are highly sensitive to the lack of one MBP 
allele. We found reduced pre-pulse inhibition as a translationally valid behavioural 
readout of mental disease-associated network dysfunction, i.e. sensorimotor gating 
deficiency. As mechanisms likely contributing to this behavioural abnormality, we 
detected mild alteration in myelin ultrastructure and brain metabolism in association 
with microgliosis. Even though it is still unclear how and when the lowered MBP levels 
in schizophrenia are induced, we show for the first time that MBP reduction by itself 










2.1 Brain white matter: an overview 
The central nervous system (CNS) is conventionally and anatomically subdivided into 
two main compartments, namely grey and white matter. The grey matter is composed 
mainly of neuronal cell bodies and dendrites, whereas the white matter, which makes up 
for roughly 40% of the human brain, comprises glial cells (astrocytes, microglia and 
oligodendrocytes) and axons ensheathed by a proteolipidic multilamellar structure, 
called myelin(Morell 1980). Historically, glial cells were considered solely the “glue” 
CNS, but now it is clear that this cell sub-population, constituting more than 50% of the 
total cell pool in the CNS, contributes to many vital processes in the CNS (Bercury and 
Macklin 2015).  
 
Astrocytes are the most abundant cell subtype in the CNS. They can be morphologically 
classified into two groups, i.e. protoplasmic astrocytes and fibrous astrocytes.  
Protoplasmic astrocytes are mainly found in the grey matter and form contact with 
synapses; fibrous astrocytes are typically detected in the white matter and they make 
contact with the node of Ranvier (Sofroniew and Vinters 2010). Astrocytes have an 
important role in the clearance of neurotransmitters at the synapse, in the stability of the 
oligodendrocyte-derived myelin sheath and in the process of myelination (Ishibashi, 
Dakin et al. 2006, Freeman and Rowitch 2013). Additionally, astrocytes are crucial for 
the formation of the Blood Brain Barrier (BBB), for the appropriate blood distribution 
in the CNS and they are often involved in inflammatory response in the injured CNS 
(Freeman and Rowitch 2013). Astrocytes exhibit electrical activity, favoured by the 
presence of sodium and potassium channels at the membrane and by intracellular 
machinerythat is responsive to the increase of intracellular calcium (Sofroniew and 
Vinters 2010). 
 
Microglia are CNS-specific immune cells, which derives mainly (but not entirely) from 
the primitive macrophage coming from the embryonic yolk sac (Nayak, Roth et al. 
2014). Interestingly, it has been recently showed that in adult mice (when required) 
microglia can originate from fast proliferation and differentiation of nestin-postive cells 






ramified morphology, with small soma and fine cellular processes, and they keep 
extending and retracting their processes to scan the CNS environment. In case of injury 
in the CNS, microglia changeto aamoeboid morphology, with short and thick processes, 
reorganise the surface molecules and release immunoregulatory or pro-inflammatory 
components (Orr, Orr et al. 2009, Kettenmann, Hanisch et al. 2011). 
On top of the immune surveillance task, microglia participate to promoting neuronal 
survival, synaptogenesis, myelin maintenance and re-myelination(Miron, Boyd et al. 
2013, Nayak, Roth et al. 2014). 
 
Oligodendrocytes are the cells dedicated to the formation of myelin in the CNS. An 
oligodendrocyte could myelinate up to 50 axons, ensuring (1) the proper electrical 
conduction along the axon and (2) an appropriate axonal support (Baumann and Pham-
Dinh 2001, Simons and Trotter 2007) 
 
2.2 Myelin and myelination in the CNS 
2.2.1.Oligodendrocytes precursor cells and mature oligodendrocytes  
 
Oligodendrocytes originate from the maturation of neural stem cells-derived 
Oligodendrocyte Precursor Cells (OPCs). These precursors, identified by the expression 
ofplatelet-derived growth factor receptor (PDGFR)-alpha and neural/glial antigen 
(NG) 2 markers, can arise from the ventral and dorsal embryonic spinal cord and from 
the ventral and dorsal forebrain, depending on the stage of development (Richardson, 
Kessaris et al. 2006, Bercury and Macklin 2015). The spatiotemporal distinction of 
OPCs is also accompanied by differencesin the expression of transcription factor, which 
appears to be specific to each OPC subpopulation (Chong and Chan 2010). Part of the 
OPCs remains in the precursor stage. These precursors reside in the CNS as a potential 
reservoir of undifferentiated cells for the adult CNS.If required,they can be pushed to 
maturation at later stages, for instance, to support adult myelination(Chong and Chan 
2010).While a pool of OPCs remains in the precursor stage, another pooldevelops 
towards the status of mature oligodendrocyte already at early stage of the CNS 
development (Nishiyama, Komitova et al. 2009). The process of maturation requires 




Extrinsic and intrinsic signals regulate proliferation, migration and differentiation of 
OPCs. For instance, it has been shown that overexpression of PDGF by neurons induces 
OPC proliferation (Chong and Chan 2010). Furthermore, electrical activity, contact with 
axons and glutamate signalling can influence OPCs proliferation, migration and 
differentiation (Boiko and Winckler 2006, Gudz, Komuro et al. 2006). This highlights 
the importance of the communication between OPCs and neurons for the proper 
formation and functioning of the CNS, and for the proliferation and differentiation of 
OPCs (Gudz, Komuro et al. 2006, Chong and Chan 2010).However, even in the absence 
of external cues, OPCs can still follow an intrinsic program of proliferation and 
maturation, suggesting that OPCs have an intrinsic timer that regulates their fate(Chong 
and Chan 2010). 
Upon the combination of extrinsic and intrinsic cues, OPCs progress towards the mature 
status. In this phase, the Oligodendrocyte Transcription Factor 1(Olig1) contributes 
actively to the transcription of several myelin-related genes, i.e. Myelin Basic 
Protein(Mbp), Proteolipid Protein (Plp) and Myelin Associated Glycoprotein (Mag) 
genes (Xin, Yue et al. 2005, Dai, Bercury et al. 2015). 
 
Mature oligodendrocytes originate the multilamellar lipoproteic ensheathment of CNS 
axons, i.e. CNS myelin. In the human CNS, myelin wraps around axons of at least 1µm 
Figure 1.Developmental stages from neural stem cell to mature oligodendrocytes. 
NG2 and PDGFRα are absent in neural stem cells, but they are specifically expressed in 
proliferating (proliferation = semicircular arrows) progenitor cells. Polidendrocytes 
(commonly accepted as OPCs) are rich in processes, whose size and number are 
spatiotemporally regulated. Upon differentiation OPCs stop expressing NG2 PDGFRα 
and start expressing mature oligodendrocyte molecules, like myelin basic protein 
(MBP). 






diameter (Sherman and Brophy 2005), whereas in the mouse corpus callosum myelin 
can be detected around 0.2µm-diameter axons  (Waxman and Swadlow 1976, Sturrock 
1980). 
 
2.2.2.Myelin biogenesis: processes elongation and axon ensheathment.  
 
As anticipated, myelin derives from the growth and protrusion of oligodendrocyte 
processes that make contact and wrap concentrically around axons at periodically 
discontinuous points, namely the internodes. The myelinated internodes - about 150µm 
in length - alternate with the node of Ranvier, where sodium ion channels cluster instead 
(Deber and Reynolds 1991, Sherman and Brophy 2005). Once the OPCs reach their 
destination, they start extruding and retracting their processes, scanning the surrounding 
environment. The myelination process begins when the tip of an OPC process 
establishes contact with the axon to myelinate. Axon diameter and integrin-mediated 
axon-glia interaction seem to be important factors for an OPC to selectively start 
myelination (Camara, Wang et al. 2009, Lee, Leach et al. 2012). Moreover, it has 
recently been shown in zebrafishthat neuronal activity works as a cue for OPCs 
specification and as a signal forstabilising the glial-axon contact for 
myelination(Petersen and Monk 2015). Nevertheless, the complete molecular 
mechanism involved in the selection of a specific axon and in the stability of the glia-
axon connection is not fully understood. Even if the molecular players are not disclosed 
yet, it is known that such contact creates a commitment between axon and OPC, 
stimulates the polarisation of the OPC molecular machinery towards the axon-glia 
interaction site, and induces the consequent evolution of the OPC towards myelinating 
oligodendrocyte status (Simons and Nave 2015). The biogenesis of the myelin 
membrane requires extreme extension of the oligodendrocyte processes; a rough 
estimation of the oligodendrocyte processes growth in rat brain during myelination 
revealed that the membrane surface area increases at a rate of 5–50x103 µm2/cell/day 
(Baron and Hoekstra 2010). Additionally, specific sorting of myelin components is 
required to ensure the proper assembly of the myelin sheath. To fulfil these demands, 
myelin components are assembled in proteolipidic domains (lipid rafts) in the Golgi 
apparatus and then delivered via non-targeted vesicular transport to the myelinating 
processes. A change in the balance of endo-/exocytosis pathway is speculated to be a 
crucial step to increase the transport rate of membrane component to the 
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oligodendrocyte plasma membrane, whereas  endocyticrecycling, feature of 
maturingoligodendrocytes, seems to ensure spatiotemporal specificity in the myelin 
biogenesis and local membrane remodelling (White and Kramer-Albers 2014). In the 
process of endocytic recycling, myelin proteins in the plasma membrane are re-
internalised and directed to endocytic compartments; from there the proteins are then 
sorted to specific domains in the plasma membrane (Fig. 2)(Maxfield and McGraw 
2004, Winterstein, Trotter et al. 2008).  
It is worth mentioning that neuron-to-glia signalling regulates the endocytic sorting and 
trafficking of PLP, underlying once more the importance of neuron-glia communication 
for the process of myelination (Simons and Trotter 2007, Winterstein, Trotter et al. 
2008,White and Kramer-Albers 2014). 
 
How oligodendrocyte processes can finally wrap around the axons and originate the 
compact myelin structure has been subject of discussion for several years. So far, few 
models have been proposed.  
The first suggested model, later defined as Carpet crawler, derived from a study in cat 
spinal cord. The author claimed that oligodendrocyte processes would entirely cover the 
axonal area - that would later become the internode - before making the first turn. The 
ensheathment would proceed until myelin had reached the appropriate thickness 
(Bunge, Bunge et al. 1961). 
However, ultrastructural observations of the growing myelin sheath revealed clear 
inconsistency with this model.In particular, the different layers of growing myelin often 
show variable length all along the internode (Knobler, Stempak et al. 1976), which is 
Figure 2.Myelin proteins trafficking 
and membrane remodelling.Myelin 
proteins can be internalised via clathrin-
dependent or clathrin-independent 
endocytosis. They are sent to the 
endosomal compartment (dependent on 
the protein) and from there they are 
sorted and recycled to the appropriate 
myelin domain.  







physically incompatible with the suggestion that oligodendrocyte processes would 
entirely cover the future internode since the first wrap. 
The more recent liquid croissant model tried to explain the contradiction of the previous 
prototype.  
In this model the oligodendrocyte process - reminiscent of a dough edges of a croissant 
- would be “poured out” in a triangular shape and, under the guidance of the axonal 
proteins, it would spread along the future internode (Sobottka, Ziegler et al. 2011).  
The most updated model of myelin wrapping was published in 2014. Via the 
combination of in vivo live imaging and ultrastructural analysis, it was possible to 
confirm that myelin formation occurs through the wrapping of the triangular-shaped 
inner tongue (leading edge) around the axon. The “wrapping movement” is also 
accompanied by a lateral growth of each individual myelin layer. This model also shed 
light on the route of communication between the leading edge and the axon. In fact 
transient cytoplasmic channels, regulated by increase in phosphatidylinositol-(3,4,5,)-
triphosphate (PIP3), are open during myelin growth, as a shortcut to transport myelin 
components to the leading edge. Cytoplasmic channels are normally closed after 
completion of the myelin growth. Interestingly, in adult mice they could be reopened in 
case of PIP3 increase, leading to a consequent increase in myelin thickness (Snaidero, 
Mobius et al. 2014). This feature indicates that myelin is a dynamic structure that 




Myelin has a unique composition that distinguishes it from all the other biological 
plasma membranes. In vivo, the water content of myelin is around 40% and the dry 
weight of myelin is composed of 70-80% of lipids and 20-30% of proteins, which 
ensure to myelin a very high lipid-to-protein ratio (around 0.25) (Quarles 2006, 
Aggarwal, Yurlova et al. 2011, Aggarwal, Yurlova et al. 2011). In particular, myelin is 
rich in glycosphingolipids (about 27% of the total lipid content in the form of 
galactosylceramide and sulfatide), plasmalogens (about 16% of the total lipid content) 
and cholesterol (crucial for defining the fluidity of the myelin sheath) (Quarles 2006, 
Aggarwal, Yurlova et al. 2011, Aggarwal, Yurlova et al. 2011). Galactosylceramide, 
together with its sulfatated and hydroxylated forms, is relevant for the interaction of 
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oligodendrocytes and axons at the paranodes and for the correct organisation of the Na+ 
channel at the node of Ranvier; plasmalogens seem to protect the myelin sheath from 
oxidative stress; cholesterol was proven to be a rate-limiting factor for myelin 
production (Jahn, Tenzer et al. 2009, Saher, Quintes et al. 2011). This high lipid 
composition limits the passage of ions through the myelin sheath, ensuring electrical 
insulation (Fitzner, Schneider et al. 2006, Chrast, Saher et al. 2011). 
 
The protein composition of the CNS myelin is also very peculiar, with only three 
members accounting for the major proportion of myelin-related proteins, i.e. PLP (30-
54% of the total proteins), MBP (22-35% of the total proteins) and 2′:3′-Cyclic 
nucleotide 3′-phosphodiesterase (CNP, 4-15% of the total proteins) (Jahn, Tenzer et al. 
2009). These proteins specifically occupy defined compartments of the myelin structure.  
Ultrastructural observations of a myelinated axons (cross-sectionally and longitudinally) 
via Electron Microscopy (EM) reveals two main domains of the myelin sheath: the 
compact myelin and the non-compact myelin (Fig. 3).  
Figure 3.Representation of the myelin structure with the major myelin proteins. 
The cartoon shows a myelinated axon with three internodes and the representative distribution 
of sodium and potassium channels. EM images offer cross-sectional (left) and a longitudinal 
(right) view, respectively of the internode and of the paranode.  
The cartoon (top) shows the different layers of the myelin sheath surrounding the axon (left), 
with the main proteins of the compact myelin (right).   






These two domains differ in morphology, function and protein composition (Quarles 
2006, Simons and Nave 2015). 
The compact myelin consists of tightly apposed oligodendrocyte plasma membranes. In 
this domain, the compaction of the intracellular surface of the plasma membrane 
extrudes the cytosol, originating the so called Major Dense Line (electron-dense layer in 
the EM micrographs); the apposition of the extracellular surface of the oligodendrocytes 
plasma membrane gives rise to the so called Intraperiod Line (electron-light layer in the 
EM micrographs) (Quarles 2006). The protein composition of the compact myelin is 
less heterogeneous than the one of the non-compacted myelin, yet this compartment 
contains the most abundant proteins of myelin, i.e. PLP/DM20 and MBP.  
PLP gene encodes two main protein isoforms: PLP and DM20, which differ only for 35 
additional amino acids at the cytosolic extremity, missing from DM20.  
PLP is a tretraspanning protein necessary for the formation of the Intraperiod Line of 
myelin. Although the structural similarity with DM20 would point in the direction of a 
comparable functionality of the two proteins, it is still unclear whether DM20 could 
make up for the absence of PLP in myelin compaction (Quarles 2006, Fulton, Paez et al. 
2010). Beside the structural function, PLP seems to be involved in the exchange of ions 
across the oligodendrocytes plasma membrane and in the signal transduction between 
extracellular matrix and intracellular space of the oligodendrocytes. Additionally, some 
evidences propose a role for PLP in the maturation and migration of OPC and in the 
oligodendrocyte survival, via influence on the apoptotic cascade and on the 
mitochondria function(Quarles 2006, Fulton, Paez et al. 2010). PLP seems also to be 
involved in the myelin biogenesis, via binding to lipid rafts cholesterol; the delivery of 
PLP from late endosome to the plasma membrane via exocytosis seems to be promoted 
by signalling from neurons (Quarles 2006, Trajkovic, Dhaunchak et al. 2006, Fulton, 
Paez et al. 2010, White and Kramer-Albers 2014). MBP is the second most abundant 
protein of the myelin sheath and it mediates the apposition of oligodendrocyte 
intracellular surfaces to drive myelin compaction. Its function will be more extensively 
explained in section 2.2.4. 
 
The non-compacted myelin - likely the most metabolically dynamic - comprises all the 
area of the myelin sheath where the cytoplasm of the myelinating oligodendrocyte has 
not been completely extruded via the process of compaction, namely the inner-tongue 
(in intimate contact with the axon), the outer-tongue (most distant from the axon), the 
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juxtaparanode (most likely mediating axon-glial communication and maintaining 
neuronal resting potential via voltage-gated potassium channels) and paranodal loop (in 
proximity of the nodes of Ranvier) and the cytoplasmic channels, that ensure fast 
exchange of newly synthesised membrane components from the oligodendrocyte soma 
to the leading edge during the process of myelination (Snaidero, Mobius et al. 
2014)(Poliak and Peles 2003). The non-compacted myelin contains several different 
proteins in low abundance, like Myelin Associated Glycoprotein (MAG), Sirtuin 2 
(Sirt2) and among them CNP is one of the most abundant (Nave and Werner 2014). 
CNP is also expressed in other cell types, like neurons and microglia, but is much more 
prominent in the CNS myelin (Quarles 2006, Yang, Kan et al. 2014). It is present in two 
different isoforms (46kDa and 48kDa). Both these isoforms undergo specific post-
translation modifications, namely acylation and isoprenylation at the C-terminus, which 
promotes their association to membrane components(Quarles 2006). CNP is 
fundamental for myelin-axon physiology. In mice lacking the CNP protein myelin 
appears normal, but the myelin-axon interface is affected, leading to axonal swelling 
and neurodegeneration (Lappe-Siefke, Goebbels et al. 2003). CNP is highly relevant for 
the organisation of the node of Ranvier(including the distribution of the Na
+
 channels) 
and for the proper timing of the myelin compaction, acting almost in antagonism to 
MBP. In fact,it has been reported that the absence of CNPcan significantlyspeed up the 
apposition of oligodendrocyte intracellular surfaces, mediated by MBP (Fulton, Paez et 
al. 2010, Aggarwal, Yurlova et al. 2011, Snaidero, Mobius et al. 2014). Additionally, 
CNP interacts with cytoskeleton, RNA and calmodulin, suggesting a broader range of 
function of CNP in the brain (Myllykoski, Seidel et al. 2015). 
 
2.2.4.The “classical” MBP 
 
MBP family is transcribed from a >100kb gene complex, known as golli (genes of 
oligodendrocytes lineage). Golli is located on chromosome 18, in both human and 
mouse, and the exonic sequences are highly conserved between the two species (Pribyl, 
Campagnoni et al. 1993). The golli gene presents three transcription start sites, that code 
for the classic MBPs and the golli MBPs(Fig.4). 
The golli MBPsare the products of the first transcription start site and they can be 






MBPscan perform several various functions, ranging from contribution to cell migration 
to intracellular Ca
2+
 regulation (Fulton, Paez et al. 2010).  
 
The classical MBPs (referred as MBP in the next pages) are mainly the products of the 
transcript that originates from the third transcription start site of the golli gene (7 
exons). These products give rise to several sized isoforms; ranging from 14kDa to 
21.5kDa in the mouse and from 17.2kDa to 21.5kDa in humans (Boggs 2006).  
Once the Mbp mRNA is transcribed, it assembles in granules in the soma of the 
oligodendrocyte and, thanks to the kinesin motor protein Kinesin Family Member 
(kif)1b, it is anterogradely transported on microtubules to reach the more distal 
extremity of the oligodendrocyte processes (the leading edge during myelination). Here 
it is translated and the protein is directly inserted between the cytoplasmic leaflets 
(Ainger, Avossa et al. 1997, Harauz, Ladizhansky et al. 2009).  
The appropriate translocation of the Mbp mRNA is mainly favoured by (1) RNA 
binding molecules that recognise responsive elements on the Mbp mRNA 
(Heterogeneous nuclear ribonucleoprotein - hnRNP) and by (2)RNA Localisation 
Region (RLR) at the 3’UTR of Mbp (Ainger, Avossa et al. 1997, Muller, Bauer et al. 
2013). 
The translation of Mbp is prevented during the mRNA translocation via a repressive 
mechanism, mediated by small non coding RNA and RNA binding protein(White, 
Gonsior et al. 2008, Muller, Bauer et al. 2013). Axon-glial contact at the extremity of 
the oligodendrocyte processes inhibits this repressive mechanism to ensure a 
spatiotemporally regulated translation of Mbp (White, Gonsior et al. 2008, Muller, 
Bauer et al. 2013). In vitro electrical activity of the axons has also been reported as a 
stimulating factor for Mbp translation (Wake, Lee et al. 2011). The product of the 
Figure 4.The golli-gene. The golli-gene contains exons that code for the golli-MBPs and 
for the classical MBPs. 
Figure from (Pribyl, Campagnoni et al. 1993). 
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Mbptranslation includes several intrinsically unstructured splice variants, whose 
expression is temporally and spatially regulated too. Exon II-containing isoforms - 
giving rise to 21.5kDa and 17.2kDa proteins - are mainly expressed during 
development; compared with the exon-II missing isoforms, they present 26 additional 
amino acids that most likely make them preferentially targeted to the cytosol and to the 
nucleus of oligodendrocyte(Allinquant, Staugaitis et al. 1991, Harauz, Ladizhansky et 
al. 2009). Exon II-missing isoforms - originating 14kDa and 18.5kDa proteins - gather 
at the oligodendrocyte plasma membrane instead (Allinquant, Staugaitis et al. 1991). 
Due to several post-translational modifications (i.e. deimination, phosphorylation, 
deamidation, methylation, and N-terminal acylation), each of the exon II-missing 
isoform appears in nature in differently charged isomers (Fig.5). This condition adds a 
further level of complexity to MBP and implies that, most likely, each one of the 
isomers has a different function and binding capability in the context of myelination 
(Moscarello 1997, Boggs 2006, Harauz, Ladizhansky et al. 2009). 
 
MBP performs several crucial functions in the proper assembly of the CNS myelin. Due 
to the positive charges, MBP binds the negative charges of the plasma membrane lipids 
and it has a leading role in apposing the intracellular side of the oligodendrocyte plasma 
Figure 5.The MBP family. Several different charged isomers and isoforms derived from the 
MBP gene. Alternative splicing and post-translational modification (PTM) originate a broad 
range of MBP molecules. Each one of these isomers/isoforms could have a specific function 
that does not share with the other isoform in the context of myelination and myelin 
compaction. 






membrane to form compact myelin around axons. Specifically, MBP stably interacts 
with phosphatidylinositol 4,5-bisphosphate (PIP2) and pulls together the 
oligodendrocyte plasma membrane to form the Major Dense Line. Interfering with 
MBP-PIP2 binding can be detrimental for the CNS myelin (Nawaz, Kippert et al. 2009).  
MBP is also a major player in the oligodendrocyte polarisation and in the organisation 
of myelin components. It has been showed that, following oligodendrocyte interaction 
with an axon, MBP influences the lateral organisation/clustering of lipids in the 
oligodendrocyte plasma membrane. This organised lipid distribution is lost in 
oligodendrocyte from Shiverer mouse model (lacking both Mbp alleles (Fitzner, 
Schneider et al. 2006). Additionally, MBP has a pivotal role in the mechanical extrusion 
of cytoplasm and proteins with large cytosolic domain from the myelin sheath, literally 
“zippering them out”, while pulling together the cytoplasmic side of the 
oligodendrocyte plasma membrane (Aggarwal, Yurlova et al. 2011). This sieve-like 
behaviour of MBP ensures the 
maintenance of the high lipid-to-protein 
ratio and selectively defines which proteins 
can enter the myelin sheet (Fig. 6) 
(Aggarwal, Yurlova et al. 2011). 
Additionally, MBP binds in vivo to tubulin 
(Harauz, Ladizhansky et al. 2009) and 
several works demonstrated the ability of 
MBP to interact in vitro with actin 
filaments at the leading edge during myelin 
sheath formation. The binding to actin 
filamentswas speculated to be a hint on the 
participation of MBP also in the 
membrane extension and wrapping 
(Boggs 2006, Boggs, Rangaraj et al. 
2011). Indeed recent publications 
suggest that actin disassembly is 
necessary for myelin wrapping and it 
has been proposed that MBP competes with protein involved in actin disassembly to 
bind to PIP2. This would displace (and consequently activate) “actin disassembly 
proteins”, indirectly boosting myelin wrapping (Zuchero, Fu et al. 2015).  
Figure 6.Sieve-like behaviour of 
MBP.MBP zippers out the cytoplasm and 
the proteins with large cytosolic domain 
leading compaction of the myelin sheath. 
Figure from (Zuchero and Barres 2011) 
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For its disorganised chemical structure it is believed that MBP could adapt to many 
more different interaction partners, which makes this protein probably one of the most 
crucial, yet not totally understood, molecules of the CNS.  
 
2.3.The relevance of myelin and myelination 
 
Rapid and synchronised electrical conduction along axons is a priority in animals with 
sophisticated behaviour. To facilitate electrical conduction, evolution has offered the 
ensheathment of axons by myelin, whose thickness is proportionally dependent on the 
axon diameter. Due to this dependence, myelin thickness is estimated via g-ratio, the 
index derived from the ratio of the axonal diameter to the total outer diameter (i.e. axon 
diameter + myelin diameter). Theoretical estimation of the optimal g-ratio predicted 
values ranging from 0.6 to 0.7, however these values do not apply to all the myelinated 
nerve fibres of the nervous system (Purger, Gibson et al. 2015).  
Myelin wraps around almost the whole length of the axon, leaving uncovered only the 
nodes of Ranvier. As insulating membrane, myelin reduces the transverse capacitance 
between the intra- and extra-axonal environments, it increases the transverse resistance 
of adjacent internodes and it reduces axonal membrane capacitance. In this way, 
electrical current flows from a node of Ranvier to the next, without dissipating, leading 
to 20-100-fold faster nerve saltatory conduction (Hartline and Colman 2007, Nave and 
Werner 2014). The fine tuning of neuronal synchrony could be promoted by change in 
the conduction velocity through modification of myelin thickness (Pajevic, Basser et al. 
2014).  
 
Myelin is not only orchestrating electrical conductivity, but it has been recently reported 
to be pivotal for metabolic and trophic support of the axons. For instance, vesicles 
transfer from oligodendrocytes to axons could be a route for transferring support 
molecules(Kramer-Albers, Bretz et al. 2007, Fruhbeis, Frohlich et al. 2013). Moreover, 
mature oligodendrocytes produce lactate and pyruvate via aerobic glycolysis 
(Funfschilling, Supplie et al. 2012). The lactate is supplied to axons through a glial 
lactate transporter and axons metabolise it when other energy sources are not available. 






intimate dependence of the axon to the myelin sheath (Lee, Morrison et al. 2012, Nave 
and Werner 2014). 
Is then myelin a passive component that ensures viability and functionality of the 
axons? No, myelin is more than that. Myelin is not a static structure that wraps around 
axons only to ensure conductivity and metabolic support. Myelin starts developing early 
in life both in human and rodents; while rodents myelination reaches its peak around 
post-natal day 23 (P23)(Foran and Peterson 1992)in human the development continues 
through adulthood, reaching the maximum peak around middle age (Miller, Duka et al. 
2012).Moreover, both in human and in rodents, white matter content reduces in 
physiological ageing (Sturrock 1987, Haroutunian, Katsel et al. 2014). Myelin is a 
dynamic ensheathment that also changes in response to axonal and environmental 
stimuli (Bechler and ffrench-Constant 2014). The mechanisms regulating myelin 
plasticity have just started being disclosed. For instance, as already mentioned in the 
previous sections, in vitro electrical activity of the axons has a direct influence on the 
translation of MBP (Wake, Lee et al. 2011), and it inhibits OPC proliferation to promote 
differentiation (Stevens, Porta et al. 2002) and consequent myelination. This suggests 
that changes in electrical activity can directly promote myelin formation. On the other 
hand, blockade of the action potential has been proven to reduce OPC proliferation and 
cause hypomyelination (Barres and Raff 1993, Demerens, Stankoff et al. 1996). 
In the orchestration of in vitro myelin formation, different frequencies of electrical 
stimulation could have opposite effects (Stevens, Tanner et al. 1998), pointing out how 
myelination plasticity is not only a numb reaction to electrical activity, but the elegant 
response to a defined and specific electrical stimulus.  
In vitro studies find further support from in vivo experiments. In zebrafish, neuronal 
activity and synaptic vesicles release influencethe process of myelination (Hines, 
Ravanelli et al. 2015, Mensch, Baraban et al. 2015). Optogenetic stimulation of the 
cortical layer V in wild-type mice leads to an increase of OPC proliferation and 
differentiation and a consequent decrease in myelin g-ratio; interestingly, these cellular 
changes underlie the acquisition of a complex motor phenotype, suggesting that myelin 
plasticity and behavioural performances are strictly interconnected (Gibson, Purger et 
al. 2014). 
Positive and negative environmental stimuli also profoundly affect CNS myelination.  
For instance, alteration in the sleep pattern alters myelin structure and forced sleep 
deprivation can be detrimental on myelination; in fact, mice undergoing normal sleep 
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report higher rate of OPC proliferation than mice subjected to forced sleep deprivation 
(Bellesi, Pfister-Genskow et al. 2013). Sleep has been described as “the price we pay for 
plasticity” and during sleep we consolidate and integrate memory (Tononi and Cirelli 
2014), so it appears that myelin exerts its plastic adaptation to environmental stimuli 
even during sleep.   
As much as forced sleep deprivation alters myelin, also stress and glucocorticoids have 
been reported to change oligodendrogenesis in rat hippocampus (Chetty, Friedman et al. 
2014). Moreover, it has been observed that social and sensory deprivation can reduce 
myelin thickness and myelin-related proteins in mice (Liu, Dietz et al. 2012, 
Makinodan, Rosen et al. 2012, Barrera, Chu et al. 2013). Intriguingly, such impairment 
in myelination can have long-term consequences only if the negative environmental 
experience takes place during “developmentally critical periods” (P21-P35) (Liu, Dietz 
et al. 2012, Makinodan, Rosen et al. 2012, Barrera, Chu et al. 2013). Not surprisingly, 
enriched environment can, on the other hand, promote myelination in rats (Yang, Li et 
al. 2013) and it has also recently showed that OPC and myelination are crucial for mice 
to learn complex motor tasks (McKenzie, Ohayon et al. 2014)and motor learning per se 
can increase white matter in rats (Sampaio-Baptista, Khrapitchev et al. 2013).  
The discoveries in rodents are in line with human data. Extensive learning of specific 
motor tasks has been associated with increase in white matter content(Bercury and 
Macklin 2015).  
Learning how to read and improving cognitive functions correlate with white matter 
development in children (Fields 2005) and even Albert Einstein’s intelligence has been 
correlated to the size of his corpus callosum, highly myelinated area of the brain(Men, 
Falk et al. 2014). 
Furthermore, the capability of learning non-native speech sounds also correlates with 
white matter size, and social cognition (acquired during adolescence) develops in 
parallel to an increase in white matter density in the frontal area of the brain (Paus 
2005).  
Not surprisingly, adaptiveness of myelination is a double-edge sword. Being on the one 
hand a footprint and an irreplaceable requirement for high cognitive and social 
functions, on the other hand, myelin is extremely sensitive to insults.Expectedly, any 
small abnormality in the proper myelin wrapping could lead to biological and 







2.4.Myelin abnormalities in schizophrenia: focus on MBP  
2.4.1.Schizophrenia 
 
Schizophrenia is a dramatic and debilitating psychiatric disorder, presenting a lifetime 
risk in the order of 0.7-1% in the overall world population (van Os and Kapur 2009, 
Kas, Kahn et al. 2011). Men are slightly more likely to develop schizophrenia and they 
tend to show an earlier onset of the pathology (Aaron T. Beck 2011). The impact is 
detrimental both on the quality of life of patients and their family - often subjected to 
public stigma (Corrigan and Watson 2002) - and it is a burden on the health care system 
economy (Insel 2010). The disease is generally diagnosed in the late adolescence/early 
adulthood (Walker, Kestler et al. 2004), and it is usually preceded by signs of 
behavioural dysfunctions (prodromal phase), like reduced tolerance to normal stress, 
higher emotionality and alteration in body perception (Klosterkötter, Hellmich et al. 
2001).However, slight delay in developmental milestones (i.e. walking) and non-
specific emotional and behavioural disturbances are sometimes detectable already 
during childhood in individuals who later develop the pathology (Welham, Isohanni et 
al. 2009). 
Schizophrenia is characterised by a broad spectrum of symptoms which could be 
subdivided in “Positive Symptoms” (hallucinations, thought disorders, delusions), 
treatable with the current available antipsychotic, “Negative Symptoms” (social 
withdrawal, loss of affect) and “Cognitive impairment-related Symptoms”, both 
significantly less responsive to the standard treatments (Walker, Kestler et al. 2004, 
Aaron T. Beck 2011). 
The aetiology of schizophrenia is not clear, but twin/family studies have proven that 
there is a genetic contribution to the pathology (Sullivan, Daly et al. 2012). However the 
concordance rate in monozygotic twin studies is only 48%, indicating that the genetic 
input to the disorder is only partial and that non-genetic factors (i.e. environment and 
gene-environment interaction) have a crucial influence on the development of 
schizophrenia (van Os, Kenis et al. 2010, Sullivan, Daly et al. 2012). 
The gene-environment interaction and the complexity of schizophrenia have become 
even more evident in the last decade, when genome-wide association studies(GWAS) 
have replaced linkage studies in the field of schizophrenia research. Case-control studies 
of substantial size (around 20000 individuals per group), comparing healthy individuals 
versus schizophrenic patients, have solidly predicted several candidate genes for 
INTRODUCTION 
40 
schizophrenia(Consortium 2011). However, as expected, the index of the strength of the 
association between the genotype and the disease, defined as odds ratio (OR), ranges 
between 1.04 and 1.26(Consortium 2011). These results underlie a minimal contribution 
of each genetic factor to the disorder.Moreover they raise the hypothesis that genes by 
themselves are not sufficient to cause the pathology and that environmental and gene-
environment interaction influences are also involved in the aetiology of schizophrenia 
(van Os, Kenis et al. 2010). Furthermore, the results from GWAS have indirectly 
pointed out other two important factors to understand schizophrenia. First of all, we 
could expect unexpressed genetic vulnerabilities for schizophrenia to be common in the 
general population, further justification for the low OR. Secondly, it is also plausible 
that specific genetic risk factors could contribute to defined sub-phenotype of the 
disease and not to the overall pathology (Walker, Kestler et al. 2004).  
Several biological mechanisms have been involved in schizophrenia and uncountable 
“hypothesis of schizophrenia” have been proposed. Structural (loss of grey matter, 
alteration of white matter, increase ventricles size) and functional changes seem to 
affect multiple areas of the brain in schizophrenia patients(Buckley 2005, Gur and Gur 
2010). Experimental evidences reported alteration of neurotransmitters (dopamine, 
gamma-Aminobutyric acid –GABA- , glutamate, and serotonin) and their 
receptors/transporters(Ross, Margolis et al. 2006, Howes, McCutcheon et al. 2015, 
Spies, Knudsen et al. 2015). Inflammation and increase in inflammation markers have 
also been consistently associated with schizophrenia (Fillman, Cloonan et al. 2013, 
Khandaker, Cousins et al. 2015). Furthermore, altered adult neurogenesis (Reif, Schmitt 
et al. 2007), abnormalities in synaptic pathway, in connectivity and in neural synchrony 
(Uhlhaas and Singer 2010, Hall, Trent et al. 2015) have been disclosed in schizophrenia 
patients. Even faster telomere erosion has been reported in schizophrenia patients (Kao, 
Cawthon et al. 2008).  
Reconcile all these different discoveries is not trivial. Consequently, in order to reduce 
such genetic and phenotypical complexity, it is helpful to focus on a more 
basic/elementary phenotypes common to several schizophrenia cases (Gottesman and 
Gould 2003). In the last decades, due to the improvement of the Magnetic Resonance 
Imaging (MRI) technology, it emerged a new pathological feature of schizophrenia, i.e. 
alteration in myelin structure. As already mentioned, myelin exerts multiple functions 






myelinated fibres connect and synchronise various brain regions, maybe also indirectly 
influencing neurotransmitter release. Thus, one could speculate that myelin alteration 
could be one of the schizophrenia sub-phenotype that might explain and link the 
misbalances of the other signalling pathways (Takahashi, Sakurai et al. 2011). 
 
2.4.2.Myelin abnormalities in schizophrenia patients 
 
It has been known for long time that connectivity and white matter are altered in 
schizophrenia (McGuire and Frith 1996, Zalesky, Fornito et al. 2011). Considering the 
already clarified importance of myelin in high cognitive functions and electrical 
synchrony among different brain regions, this is not surprising. The prolonged 
development of myelination in humans and the high adaptiveness of the white matter 
could indeed represent a double-edged sword. It would ensure the complexity of human 
reasoning, but it would also add a weakness to the CNS, since myelin is so highly 
responsive also to adverse stimuli (Miller, Duka et al. 2012, Haroutunian, Katsel et al. 
2014). 
It is not clear whether the abnormalities in myelin are causative of schizophrenia or just 
a consequence of the disease, yet numerous evidences confirm abnormalities in white 
matter tract in schizophrenia patients versus healthy controls and it is crucial to 
understand the biological and phenotypical meaning of these alterations. 
Imaging studies pinpointed alteration in myelin ultrastructure and fibres bundles. In 
particular, several experimental evidences report a reduction in Fractional 
Anisotropy (FA) and in Magnetisation Transfer Ratio (MTR), mostly in the corpus 
callosum, in the cortex, in the arcuate fasciculus and in the uncinate fasciculus in 
schizophrenia patients (Kubicki, Park et al. 2005, McIntosh, Munoz Maniega et al. 
2008, Sussmann, Lymer et al. 2009, Holleran, Ahmed et al. 2014, Li, Kale Edmiston 
et al. 2014). Abnormalities in white matter of the arcuate fasciculus are also 
associated with neurophysiological alteration in the N1 component suppression in 
schizophrenia patients (Whitford, Mathalon et al. 2011) and they are considered to be 
partially involved in the manifestation of auditory hallucination typical of 
schizophrenia patients (Hubl, Koenig et al. 2004, Whitford, Ford et al. 2012). This 
indicates that myelin alteration might be involved in the impairment of the electrical 
communication among different brain regions. Moreover, the white matter size is 
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reduced in schizophrenia patients and it seems also to be affected by a faster ageing 
process (Kochunov, Glahn et al. 2013, Balevich, Haznedar et al. 2015). 
Ultrastructural analysis of postmortem brain via conventional electron microscopy 
(EM) in the prefrontal cortex reveals a reduction of oligodendrocyte density and 
apoptotic/necrotic oligodendrocytes surrounded  by microglia in patients versus 
healthy controls (Uranova, Orlovskaya et al. 2001, Uranova, Vostrikov et al. 2004, 
Vostrikov and Uranova 2011). 
Proteomic and gene-expression studies further support imaging and EM findings, 
showing  alteration of the expression of myelin-related genes and proteins in the 
prefrontal, frontal and anterior cingulate  cortices(Table A - Appendix)(Hakak, 
Walker et al. 2001, Flynn, Lang et al. 2003, Tkachev, Mimmack et al. 2003). The 
altered expression of myelin gene further supports the involvement of myelin 
abnormalities in schizophrenia.  
Among the several candidate gene/protein, in the last few years MBP has become 
more and more appealing for the attempt of understanding the role of myelin 
abnormalities in schizophrenia. In fact different laboratory showed a consistent 
reduction in MBP in patients with schizophrenia and other severe psychiatric illness 
versus control (Table 1). As a further support of the relevance of MBP reduction in 
schizophrenia, a recent convergent functional genomic study has reported MBP as 
one of the top genes involved in schizophrenia (Ayalew, Le-Niculescu et al. 2012).  
To elucidate the meaning and the consequences of myelin abnormalities (specifically 
MBP reduction) in schizophrenia, we need a model, that (1) presents abnormalities 
without major motor impairments, which would prevent the detection of subtle 
psychiatric phenotypes, and (2) shows a reasonable approximation of construct 
validity (Nestler and Hyman 2010).  
In the attempt of understanding the “myelin hypothesis” of schizophrenia, a few 
mouse model of dysmyelination have been proposed (Table 2). However in some of 
them the dysmyelination was quite severe, for instance in Quaking mice hoistad 
(Hoistad, Segal et al. 2009), which does not resemble the condition in schizophrenia. 
In other models, demyelinationwas induced by toxic agent and, consequently, the 
damage to the fibres was quite unspecific, i.e. cuprizone model xiao makinodan 
(Makinodan, Yamauchi et al. 2009). Last but not least, none of this model 






schizophrenia research, we decided to explore the biological and behavioural 





























(previous page)Table 1 Reduction of MBP in severe psychiatric illness.  
Reference from top to bottom: (Honer, Falkai et al. 1999, Tkachev, Mimmack et al. 2003, 
Chambers and Perrone-Bizzozero 2004, Martins-de-Souza, Gattaz et al. 2009, Parlapani, 
Schmitt et al. 2009, Matthews, Eastwood et al. 2012, Mosebach, Keilhoff et al. 2013, Xiong, 
Zeng et al. 2014, Wesseling, Gottschalk et al. 2015) 
 
Table 2. Available animal models to study myelin alteration in schizophrenia 
Table from (Takahashi, Sakurai et al. 2011) 
References from top to bottom:(Stefansson, Sigurdsson et al. 2002, Hu, Hicks et al. 2006, 
Hsu, Woodroffe et al. 2007, Roy, Murtie et al. 2007, Savonenko, Melnikova et al. 2008, 
Taveggia, Thaker et al. 2008) tanaka (Tanaka, Ma et al. 2009) 
 
2.5.Shiverer heterozygous: a model to unravel schizophrenia sub-phenotype? 
 
Ablation of MBP can be achieved by deleting 5 of the 7 exons of the allele coding 
for the classical MBP (see section 2.2.4). When the deletion interests both MBP 
alleles, as in shiverer mice, this natural occurring mutation leads to complete loss of 
myelin compaction in the CNS. Consequently these mice show a strong motor 
phenotype (they are literally shivering) in parallel to a very limited lifeexpectancy 
(Chernoff 1981, Readhead, Takasashi et al. 1990).  
Due to the motor impairment and to the short life expectancy, this model does not fulfil 
our translational purposes of understanding mild dysmyelination in schizophrenia. On 
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the contrary, heterozygous shiverer (here referred to as Mbp+/- mice) miss only one 
allele coding for the classical MBP. As consequence, these mice express 50% MBP 
mRNA and protein, but this amount has been claimed to be sufficient to ensure normal 
motor performances on the rota-rod and normal myelination (Barbarese, Nielson et al. 
1983, Kuhn, Petroulakis et al. 1995). Indeed, myelination of the optic nerve of Mbp+/-  
wasreported to be completely comparable to the one in the wild-type (Shine, Readhead 
et al. 1992); moreover, the phenotype of the shiverer can be rescued with 25% of the 
physiological amount of MBP, supporting the idea the one Mbp allele could be more 
than sufficient to ensure myelination and myelin compaction (Readhead, Popko et al. 
1987).  
Due to the claimed comparability between Mbp+/- and wild-type mice,Mbp+/- mice 
have been neglected or even used as “healthy controls”(Tu, Kim et al. 2013). 
However, it recently emerged that this mouse model might have been overlooked. 
Visual Evoked Potential (VEP) measurements comparing Mbp+/- mice and wild-
type revealed a mild but significant increase (+7%) in the latency of the 
neurophysiological component. This readout might disclose a mild impairment in 
brain electrical synchrony (Martin, Hiltner et al. 2006), phenotype often found in 
schizophrenia patients. Furthermore, a developmental delay in myelin compaction 
and an alteration in the brain metabolism of young Mbp+/- mice have been reported 
(Snaidero, Mobius et al. 2014, Takanashi, Nitta et al. 2014). This could underscore a 
more general delay in developmental milestones, often reported in schizophrenia 
patients before the onset of the pathology (Welham, Isohanni et al. 2009). 
These subtle anomalies that emerged in Mbp+/- mice suggest that a mild reduction in 
MBP might not be detrimental for gross motor functions and basic behaviour, but it 
could have an effect on the fine tuning of the brain. Indeed schizophrenia is not 
characterised by extreme dysmyelination and motor deficits, but by a subtle 
alteration in myelin structure, accompanied by misbalances of neurotransmitter and 
metabolites and by neural desynchronisation.   
For these reasons, Mbp+/- mouse appeared to be a suitable model to explore the 
consequences of a suboptimal MBP amount, often detected in schizophrenia. Since it 
is not clear at which time in life the reduction of MBP has a pathological effect on 
the patients, we screened this mouse model at different time points, i.e. young (3 






the impact of such reduction on myelin structure in a life-span fashion and from there 
(2) to explore more in depth the behavioural and biological consequence of a “mild 
demyelination sub-phenotype”, with the final aim of unravelling at least part of  the 
complex disease called schizophrenia 
. 
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3. METHODS AND MATERIALS 
 
All experiments were approved by the local animal care and use committee in 
accordance with the German animal protection law. Mice were group-housed (4-5 
animals) in standard plastic cages and they had access to food and water ad libitum. 
They were kept under a 12h light-dark cycle (lights on at 7:00am) and an ambient 
temperature of 20-22°C.  
 
3.1.RNA extraction 
Three-month, 6-month and 20-month old animals were anaesthetised with 1mL of 
avertin (1g tribromomethanol, 1mL o tetramylalchol in 71,49mL milliQ water) and the 
prefrontal cortex and brainstem were dissected from(4 animals per genotype) and stored 
at -80°C before analysis. The tissue was homogenised in Qiazol via mechanical 
breakage, chloroform was added to the homogenised suspension and the samples were 
centrifuged at 12000g for 15min at 4°C to induce separation of the RNA from DNA and 
protein content. The RNA extraction was performed via miRNeasy mini kit (QIAGEN 
#217004) following the manufacture’s instruction. The RNA concentration was 
measured via detection of the sample absorbance at OD260nm and the RNA purity was 
evaluated via OD260/OD280. The samples were stored at -80°C. 
 
3.2.Retrotranscription and Real-time PCR 
 
To measure the mRNA level of MBP, CNP, PLP, each RNA sample was diluted to 20 
ng/µL mixed with 0.6 pmol oligo dT-mix, 120 pmol of Random Hexamer (Roche) and 
retrotranscribed to cDNA with SuperScript® III Reverse Transcriptase kit 
(LifeTechnologies) according to the manufacturer’s guideline.  
The derived cDNA was then diluted 1:5 and 4µL of it were used as template for SYBR 
GREEN-based real-time PCR, accordingly to manufacturer’s protocol. The reaction was 
run in Roche LightCycler 480, each sample was assayed in triplicate and normalised to 
18s ribosomal subunit. The following primers were used to amplify the construct of 
interest:  
MBP Frw 5’-ACGGACACCCTTCCAAGTT-3’ 




MBP Rev 5’-GTGTGCCTCACCGTGAAAA-3’  
CNP Frw 5’-TAACCCTCCCTTAGCCCCTG-3’  
CNP Rev: 5’-GTCCCTAGCATGTGGCAGCT-3’,  
PLP Frw 5’-GGCTAGGACATCCCGACAAG-3’  
PLP Rev 5’-GCAAACACCAGGAGCCATACA-3’,  
18s Frw 5’-GCTCTAGAATTACCACAGTTATCCAA-3’  
18s Rev 5’-AAATCAGTTATGGTTCCTTTGGTC-3’.  
 
3.3.Protein extraction and western blotting 
Three-month, 6-month and 20-month old animals were anaesthetised with 1mL of 
avertin (1g tribromomethanol, 1mL o tetramylalchol in 71,49mL milliQ water). The 
prefrontal cortex and brainstem were dissected and stored at -80°C before analysis. The 
tissue was homogenised in lysis buffer (50mM Tris/Cl pH 7.5, 150 mM NaCl, 1mM 
EDTA, 1% Triton x-100, 0.5% Sodiumdeoxycholat) with the addition of freshly 
prepared protease inhibitors (50 µg/mL Leupeptin, 0.2 mM PMSF, 1 mM of activated 
sodium orthovandate, 30 µg/mL Aprotinin), incubated on ice for 30 minutes and 
centrifuged at 9000 rpm at 4°C for 10 minutes. Part of the samples was used to assess 
protein concentration via Folin phenol reagent (Lowry, Rosebrough et al. 1951). And 
the rest was mixed with 4X Lämmli buffer and incubated at room temperature for 30 
minutes. Comparable amounts of total protein from each experimental condition were 
separated on 15% SDS polyacrylamide gels and transferred onto nitrocellulose.  
The membranes were blocked for at least 1h at room temperature (Tris-buffered saline, 
1% Tween, 5% powder milk) and incubated overnight at 4°C with primary antibody: 
anti-MBP (1:2000, Dako), anti-CNP (1:5000, Sigma-Aldrich), anti-PLP (homemade, 
A431, 1:500) and anti-α-Tubulin (1:10 000, Sigma-Aldrich). The membranes were then 
incubated with secondary antibody, either anti-mouse or anti-rabbit (1:5000, Rockland) 
for 2h at room temperature. The intensity of the bands was detected via Odyssey 
Infrared Imaging system and quantified via Image Studio Lite software. The intensity of 
MBP, CNP and PLP were normalised to the intensity of α-Tubulin.  
 
3.4.MRI (in collaboration with Prof. Boretius, who provided the method part) 
The mice were initially anesthetized with 5% isoflurane, subsequently intubated and 
kept under anaesthesia with 1.75% isoflurane in ambient air and 5% oxygen by active 
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ventilation with a constant respiratory frequency of 85 breaths per minute (Animal 
Respirator Advanced™, TSE Systems, Germany).  
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) were 
performed at a magnetic field strength of 7T (ClinScan, Bruker BioSpin, Germany). 
MRI comprised T2-weighted images (2D FSE, TR/TE=4000/50 ms), diffusion-
weighted images (2D EPI, TR/TE= 7000/28 ms, 12 directions, b= 0/1000 s/mm²) and 3 
differently weighted 3D FLASH based datasets (TR/TE= 28/1.9 ms, flip angle=25° for 
T1 weighting and 5° for proton weighting, the later with and without additional 
magnetization-transfer weighting by Gaussian-shaped off-resonance pulses with a flip 
angle of 500° and an off-resonance frequency of 1200 Hz). Localized proton MR 
spectra (PRESS, TR/TE= 6000/10 ms) were obtained from a volume of interest (VOI) 
in the hippocampus (1.8x0.7x1.8 mm
3
), cortex (3.9x0.7x3.2 mm
3
) and corpus callosum 
(3.9x0.7x1.7mm
3
). Metabolite quantification involved spectral evaluation by LCModel 
(Version 6.3-0G, Provencher, 1993). Results with Cramer-Rao lower bounds above 
20% were excluded from further analyses. 
Maps of magnetization transfer ratio (MTR), magnetization saturation (MT sat), 
fractional anisotropy (FA), apparent diffusion coefficient (ADC), axial diffusivity (AD), 
and radial diffusivity (RD) were calculated using in-house Matlab scripts (Mathworks, 
Natick, USA). 
 
3.5.Electron Microscopy (performed in collaboration with Dr. Möbius) 
Each animal (Mbp+/- = 3; WT = 3) was anaesthetised with avertin and intracardially 
perfused with 15 ml of HBSS, followed by 50 ml of fixative (2.5% glutaraldehyde, 4% 
paraformaldehyde in PBS). The brains were dissected and 200μm coronal sections were 
cut by using a Leica VT1200S Vibratom (Leica Microsystems, Wetzlar). The genu of 
the corpus callosum was punched out of the sliced tissue and it was post-fixed overnight 
and embedded in Epon (Serva) after postfixation with 2% OsO4 (Science Services, 
Munich, Germany) and dehydration with ethanol and propylenoxid.  Semi-thin sections 
were stained with methylene blue and AzurII. Ultrathin sections were contrasted with 
1% uranyl acetate and lead citrate. Ultra-thin sections were scanned via Zeiss EM900 
Elektron-Microscop (Zeiss, Oberkochen, Germany) and digital pictures were obtained 
using the wide-angle dual speed 2K-CCD-Camera (TRS, Moorenweis, Germany). 




Myelin and axon tracings were performed on the electron microscopy pictures (at least 
15 pictures per animal) via ImageJ (http://rsb.info.nih.gov/ij/).  g-ratio, as myelin 
thickness index, and t-ratio, as inner tongue ratio, were calculated as indicated in figure 
14F’. 
 
3.6.Tissue fixation and immunohistochemistry 
Fourteen-month old animals were anaesthetised with 1mL of avertin (1g 
tribromomethanol, 1mL o tetramylalchol in 71,49mL milliQ water) and perfused with 
4% formaldehyde (FA). The fixes brains were dehydrated in 30% sucrose solution and 
stored at -80°C. Coronal sections (30µm-thick) were stained with microglia marker anti-
Iba1 (Wako, 1:1000 in 5% normal horse serum and 0.5% TritonX-100 in 1x PBS), 
followed by anti-rabbit (BRAND, donkey anti-rabbit, 594nm). Cell nuclei were 
counterstained with DAPI (4’,6-Diamidino-2-phenylindole 1:10000, Brand).  
Eighteen-month old animals were anaesthetised with 1mL of avertin (1g 
tribromomethanol, 1mL o tetramylalchol in 71,49mL milliQ water) and perfused with 
4% formaldehyde (FA). The fixes brains were dehydrated in 30% sucrose solution and 
stored at -80°C. Coronal sections (30µm-thick) were stained with myelin markers anti-
MBP (Sternberger, 1:800 in 3% horse serum and 0.5% TritonX-100 in 1x PBS), 
followed by anti-mouse (AF555, goat anti-mouse), and with anti-PLP (homemade, 
A431, 1:500 in 3% horse serum and 0.5% TritonX-100 in 1x PBS), followed by anti-
rabbit (AF488, goat anti-rabbit).  
The brain slices were dried, mounted with Mounting Medium and scanned with inverted 
epifluorescence microscope (LEICA, DMI 6000B). The analyses were performed via 
IMARIS software (http://www.bitplane.com/) and Fiji (http://fiji.sc/Fiji).    
 
3.7.Behavioural screening 
The behavioural screening of adult (>3-months old) and old (>17-months old) male 
mice was performed on 1-4 cohorts (detailed information in Table 1) of at least 10 
animals per genotype (MBP+/- vs. wild-type littermate). All the experiments were 
conducted by investigators blind to the genotype, during the light phase of the day 
(9:00-17:00). Both basic and high behavioural functions were investigated.  
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3.7.1.Elevated plus maze  
The plus-shape apparatus consisted of two walled and two open arms elevated from the 
ground. The light intensity during the test was set to 
~
130lux. The mouse was placed in 
the central platform, facing the edge where an open arm encountered a walled arm. 
Behaviour was recorded over 5 min by an overhead video camera. A personal computer 
equipped with Viewer software (Biobserve, Bonn, Germany) measured the locomotion 
(time and speed) of the animal in the open and walled arms respectively. The proportion 
of time spent in open arms (natural aversion) was used as an anxiety equivalent. 
 
3.7.2.Open field 
The apparatus consisted of a 110cm-diameter walled arena. The light intensity during 
the test was set to 
~
130lux. The mouse was released in the centre of the arena and the 
latency to reach the periphery was recorded (cutoff: 180’’). After reaching the periphery 
(or after 180’’), the mouse was allowed to freely move in the arena for 7 minutes. A 
personal computer equipped with Viewer software (Biobserve, Bonn, Germany) 
measured the locomotion (time, velocity and total distance) of the animal in the 
periphery, intermediate, centre of the arena. The time spent in the periphery 
(thigmotaxis) was used as an anxiety equivalent and the locomotion (average velocity 
and total distance) was referred as motor performances. 
 
3.7.3.Hole-board (1 day) 
The apparatus consisted of a chamber (21 × 21 × 36 cm) with a floor raised 5 cm above 
the bottom of the chamber with 16 equally spaced holes (2 cm in diameter). The animal 
was allowed to freely explore the apparatus for 5 minutes and the number of nose-pokes 
in the hole of the floor was recorded via an infrared photo beams connected to a 
computer with ActiMot software version 2 (TSE Systems GmbH, Bad Homburg, 
Germany).  
 
3.7.4.Pre-pulse inhibition of startle response (PPI) 
The animals were allocated in metal cages (82x40x40mm) and placed on a transducer 
platform that recorded movements inside an attenuating cabinet (TSE Systems, Bad 
Homburg, Germany). Startle reflex was induced by acoustic stimuli emitted by a 
loudspeaker inside the cabinet. The startle response to the acoustic stimulus was 




recorded for 260ms from the onset of the pulse. The animal underwent 2 min 
habituation to a 65dB background white noise (constant over the whole experimental 
phase) and the reaction to it was recorded over 1 minute. Then, 6 120dB stimuli of 
40ms duration were applied to decrease the influence of within-session habituation. To 
test PPI, the startle pulse (120dB intensity) was applied either alone or proceeded by a 
20ms-pre-pulse stimulus of 70/75/80dB. A delay of 100ms with background noise was 
interposed between the presentation of the pre-pulse and pulse stimulus. The trials were 
pseudo-randomized with a variable interval ranging from 8-22 second. The amplitude of 
the startle response (expressed in arbitrary units) was defined as the difference between 
the maximum force detected during the recording window and the force measured 
immediately before the stimulus onset. For each animal, the amplitudes were averaged 
separately for the startle reflex to the pulse (startle response), or for the startle reflex to 
the pulse preceded by a pre-pulse, or for the startle reflex without any acoustic stimulus. 
PPI was calculated as the percentage of the startle response using the following formula: 
%PPI=100-[(startle amplitude after pre-pulse)/(startle amplitude after pulse only)×100].  
 
3.7.5.Acoustic Startle Response 
To assess the sensorimotor reflex the animals were allocated in metal cages 
(82x40x40mm) and placed on a transducer platform that recorded movements inside an 
attenuating cabinet (TSE Systems, Bad Homburg, Germany). Startle reflex was induced 
by acoustic stimuli emitted by a loudspeaker inside the cabinet and it was measured 
over a period of 100ms. The habituation phase consisted in the administration of 
background noise (65dB) for 2min and it was followed by a recording of the baseline 
startle of the each animal at 65dB for 1min. The experimental phase consisted in the 
pseudo-randomised presentation of 40ms-duration acoustic stimuli ranging from a 
minimum of 65dB to a maximum of 120dB (inter-stimulus interval 8-22s). Each 
stimulus was administer 10 times. The average startle response amplitude to each 
stimulus was used for statistical analysis.   
 
3.7.6.Rota-rod 
The apparatus comprises a rotating drum (Med Associates Inc. Georgia, Vermont) that 
is accelerated from 4 to 40 revolutions per minute over the course of 5 minutes. The 
animal was placed on the drum and the latency to fall from the drum was detected via a 
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laser sensor located on the floor of the apparatus and recorded by the instrument. When 




The apparatus consisted of a transparent rectangular plastic surface, half of it located on 
a grey plastic supporter (ground zone) and the other half standing over the edge of the 
supporter, 1 meter above the floor (air zone). The animal was released on the edge of 
the grey plastic supporter and it was allowed to explore the area for 5 minutes. The 
activity was recorded via an overhead camera connected to the video-tracking system 
Viewer 2 (Bioserve, GmbH). The percentage of time spent by the animal in the air zone 
was consider as index of visual acuity (the less time the better the vision acuity). 
 
3.7.8.Grip strength 
The animal was lifted by the tail and it was placed on a grip strength meter (TSE 
System, GmbH), so that the forepaws could grasp a wire grid and the body could be 
parallel to the table surface. The animal was then gently pulled by its tail until it releases 
the wire. The force applied by the mouse to hold on to the wire was recorded in ponds. 
At least 3 trials per animal were carried out and the average of the values recorded was 
used for statistical analysis.  
 
3.7.9.Hot plate 
The animal was placed on a metal plate (Ugo Basile Srl, Comerio, Italy) that was 
preheated up to 55°C. The latency to show hind paw licking or jumping was recorded 
(cut off 60s). The animal was then immediately removed from the plate, to prevent 
injuries. 
 
3.7.10.Buried food test 
The first part of the test (day 1 to day 6) aimed to habituate the animal to the test 
environment (29.5 × 18.5 × 13 cm cages) and to the test food (crunchy chocolate 
cookies). On the first 3 days the animal was placed in the test cage 2 x 20 minutes per 
day. At the end of day 3, the regular food pellets in the home cage of the test animal 
were replaced by test food. From day 4 to day 6 the animal was placed in the test cage 




containing the testing food (2 x 20 minutes). On day 7 the animal was placed closed to 
the wall of the testing cage, where the testing food was hidden under 1.5 cm standard 
bedding at the opposite side of the cage. The time from the moment the mouse was 
released into the cage to the time it located the cookie and initiated burrowing was 
recorded (cut off 300 seconds). To control for other sensory, motor, or motivational 
deficiencies that might influence the food-finding latency, the test was repeated, with 
the test food placed on the bedding (visible to the mouse). All the steps performed in the 
test cage were carried out at light intensity of 50-60lux. 
 
3.7.11.Marble burying 
The light intensity was set to 60lux. A large test cage (29.5 × 18.5 × 13 cm) was filled 
with 5 cm deep layer of bedding and 24 marbles were arranged in a 6 x 4 array. The 
animal was released in the centre of the cage and let freely explore for 30 minutes. The 
number of marbles buried was counted. Marbles are considered buried if at least two-
thirds of the marble is obscured from view by bedding.  
 
3.7.12.Y-maze 
The apparatus consisted of a three walled-arms radiating maze with triangle-shaped 
central platform. The animal was released in the central area, facing the edge where two 
arms encountered, and it was allowed to freely explore the maze for 5 min. Total 
number of entries, number of triplets (the number of consecutive choices of each of the 
three arms, without re-entries during the last three choices), and alternation-ratio 
(number of triplets/(number of entries – 2)) were recorded. An arm entry was scored 
when the mouse entered an arm with all four paws.  
 
3.7.13.Three-chambered social test 
The test was adapted from previously described methods(Moy, Nadler et al. 2004). The 
social testing arena consisted of a rectangular, 3-chambered box. Transparent Plexiglas 
walls, with rectangular openings, separated the three compartments of the arena. The 
experimental procedure consisted of 4 phases: habituation, sociability, control for place 
preference biases and social memory. During habituation phase, the test mouse was 
first placed in the middle compartment and the 5-minute exploration was restricted to 
this area. During sociability phase, a new C57BL/6N male mouse of the same age 
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(stranger 1) was located inside a rectangular wire-mesh cage in one of the side chamber. 
An identical empty wire cage was placed in the opposite chamber. The test animal was 
then allowed to access all the three compartments of the arena for 10 minutes. During 
control for place preferences biases phase Stranger 1 was then moved to the other side 
compartment and the test animal was allowed to explore the arena for other 10 minutes. 
In social memory phase a second stranger (stranger 2) was placed in the previously 
empty wire-mesh cage. The test mouse was allowed to freely explore the arena, having 
now the choice between the stranger 1 (familiar) and a new stranger (novel). The time 
spent and the number of entryin each compartment was recorded by the video-tracking 
system Viewer 2 (BIOBSERVE GmbH). Sociability and social memory were calculated 
as follow:  
Sociability = [timestranger / (timestranger + timeempty)] x 100 
Social memory = [timenovel / (timenovel + timefamiliar)] x 100 
 
3.7.14.Sucrose preference 
The animal was first habituated for 48 hours to consume 2% sucrose solution from two 
100mL bottles. After the habituation session, the animal was water-deprived for 3 days. 
On each day of water deprivation, the animal was in contact for 60 minutes with two 
bottles (one with tap water and one with 2% sucrose solution) in the home cage. 
Consumption of water or sucrose solution was measured by weighing the bottles before 
and after the session. The percentage of sucrose preference (percentage) was calculated 
as follows: 
Sucrose preference = [(sucrose solution intake/total liquid intake)] x 100 
 
3.7.15.Morris water maze 
The apparatus consisted of a 110cm-diameter tank filled with opaque water (25±1°C, 
depth 300cm) and of a submerged escape-platform (10cm×10cm, 1cm below water 
surface). The animal swim pattern was documented by a video-tracking system 
(Viewer2, Biobserve GmbH, Germany). Escape latency, swim speed, and path length 
were recorded. The light intensity was set to ~100lux. 
The test consisted 5 main phases (17 day in total): visible platform (2 days), acquisition 
(hidden platform, 8 days), probe trial (1 day), reverse learning (hidden platform, 4 
days), reverse probe trial (1 day). 




Visible platform: the animal was trained for 2 days (4-trials/day) to find a submerged 
platform positioned in the centre of one of the four quadrants of the pool. A visual hint 
was given to the mouse by a small flag fixed on the surface of the platform. 
Acquisition (hidden platform): the animal was trained for 8 days (4-trials/day) to find a 
submerged platform positioned in the centre of one of the four quadrants of the pool. 
Extra-maze cues were placed on the walls of the testing room to help orientation. The 
animal was released into the water facing the pool wall at one of four start locations and 
allowed to search for the platform for a maximum of 90s. A mouse that failed to find 
the platform within 90s was guided to the platform and remained there for 20s before 
being removed from the pool. 
Probe trial: on day 11, the platform was removed from the pool and the animal was 
allowed to freely swim for 90s. The percentage of time spent in each quadrant of the 
pool was recorded. 
Reverse learning (hidden platform): The animal was trained for further 4 days (4-
trials/day) to find a submerged platform moved to the centre of a different quadrant of 
the pool. 
Reverse probe trial: on day 17 on day 11, the platform was removed from the pool and 
the animal was allowed to freely swim for 90s. The percentage of time spent in each 
quadrant of the pool was recorded. 
 
3.7.16.Novel object recognition (without and with delay) 
The test was adapted from previous published method(Bevins and Besheer 2006). The 
apparatus consisted of a grey plastic squared-box where plastic object were located 
accordingly to the test procedure. The tests were applied to adult animals (>3 months). 
They both comprised two phases: exploration phase and memory phase that were 
separated by a 30-minute time interval in case of novel object recognition with delay.  
During the exploration phase two objects of the same colour and similar shape were 
located in two opposite zone of the test arena. The animal was then released in the box 
and it was allowed to freely explore for 10 minutes. During the memory phase one of 
the two familiar object was substituted by a new one (black and of a totally different 
shape).  
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3.7.17.Novel object recognition (2) 
The test was adapted from previous published method(Roullet, Mele et al. 1996). The 
apparatus consisted of an arena with grey plastic wall and a 10 x 8 cm striped cue 
located in the inside surface. The following test was performed with old animals (> 17 
months) and it comprised 7 sessions of 7 minute each; in each session the animal was 
allowed to freely explore the environment and a video-tracking system (Viewer2, 
Biobserve GmbH, Germany) was recording the animal motion and exploration. In the 
first session, the arena was empty (habituation). From session 2 to session 4, four object 
of the same colour (white) were located at the 4 poles of the apparatus (object 
exploration). In sessions 5 and 6, one of the objects was moved to the centre of the 
arena. During session 7 (memory phase), one of the familiar white object was 
exchanged with a black one. 
 
3.7.18.LABORAS – spontaneous home cage behaviour 
The LABORAS apparatus consisted of a sensor platform (Carbon Fiber Plate 1000 mm
× 700 mm× 700 mm× 30 mm, Metris B.V., Hoofddorp, Netherlands), positioned on two 
force transducers and a third fixed point attached to a heavy bottom plate (Corian Plate 
980 mm× 695 mm ×695 mm × 48 mm). The whole structure stood on three spikes able to 
absorb vibrations. The animal was located in transparent polycarbonate cages 
(Makrolon type II cage, 22 cm× 16 cm× 14 cm) with a thin layer of bedding covering 
the floor. The cage (including the top-grid, food and drinking bottle) was suspended 
over the sensing platform. The animal was single-housed in the LABORAS cage from 
17:00 until 9:00 on the following day and the mechanical vibration derived from the 
animal behaviour were converted to electrical signals by the force transducers, 
amplified and stored in a computer. LABORAS software was then used to process the 
data and to retrieve information about the following behavioural readouts: eating, 
drinking, scratching, circling, climbing, immobility, locomotion, and grooming.  
 
3.7.19.Grasping test 
The test was adapted from the combination of the reaching chamber test(Qian, Lei et al. 
2010)and the paw preference test(Collins 1975, Ribeiro, Eales et al. 2013). 
The apparatus consisted of four in-line white plastic chambers with an exchangeable 
transparent plastic panel on the front. On each panel, in correspondence of each 
chamber and evenly distanced from the left and right sides of the chamber, were located 




four feeding tubes. Three panels with three different tube diameters (10mm, 8mm and 
5mm) were used. When required by the protocol, a guillotine door was manually used 
to obstruct the feeding tubes.  
Each animal underwent an experimental procedure three phases: (1) 2-day food 
habituation phase, when the experimental pellets were introduced in the home-cage of 
the animal; (2) 2-day learning phase, when the animal had to learn to retrieve the pellet 
from the feeding tube (day 1: big diameter, guillotine door always open; day 2: 
intermediate diameter, guillotine door closing every minute for 10 minutes); (3) 1-day 
testing phase, when the animal had to retrieve the pellet from the smallest diameter 
feeding tube (10 trials of 1 minute each). The following parameters were measured: paw 
preference, efficiency index (success in retrieving/attempts in retrieving), number of 
successes at the first attempt, time to approach the pellet, time to retrieve the pellet, 
grasping score (1 = good grasp; 0 = wrong grasp; 0.5 = the animal used the paw to 
move the pellet closer to the snout, but then it used the tongue to retrieve it) 
 
3.8.Statistical Analysis 
Between-group comparisons were performed via t test for independent samples and 
two-way analysis of variance (ANOVA or repeated-measures ANOVA). Within-group 
chance level performance (ratio or percentage values) was carried out via single group t 
tests against a chance level. Mann-Whitney U and Wilcoxon tests were applied when 
normality assumption was violated (Kolmogorov-Smirnov test). All statistics were 
performed using Prism GraphPad software or MatLab scripts (Mathworks, Natick, 
USA). Data presented in the figures and text are expressed as mean ± SEM; p values 




Several studies in post-mortem brains from schizophrenia patients revealed a reduction 
of MBP (mRNA and protein) up to 40% (Table 1). To understand the consequence of 
such reduction we extensively characterised heterozygous shiverer, here called Mbp+/- 
mice, in comparison with wild-type.  
Specifically, we attempted to clarify whether the reduction of MBP expression was 
causative of:  
(1) anomalies in the expression of other highly expressed myelin proteins, namely 
CNP and PLP  
(2) fibres damage and subtle demyelination 
(3) alteration of brain metabolism and neurotransmitters 
(4) behavioural alteration, in particular in the context of complex functions 
(sociability, learning, memory, sensorimotor gating) 
 
4.1.MBP show an age-dependent and area-specific expression pattern 
The first step to validate the mouse model was to confirm the reduction in MBP (mRNA 
and protein). Since it is not clear when the changes in MBP expression happen and 
because of the documented ageing effect on myelin and myelin-related molecules 
(Hagemeyer, Goebbels et al. 2012, Young, Psachoulia et al. 2013, Haroutunian, Katsel 
et al. 2014), three different time points were selected for the analysis, i.e. 3 months 
(young animals), 6 months (mature animals) and 20 months (senior animals).  
The quantification was restricted to two “contrasting” brain areas, i.e. prefrontal cortex 
(PFC) and brainstem. PFC is mainly composed of grey matter, it is one of the brain 
area highly affected in schizophrenia patients (Perlstein, Carter et al. 2001)and it is 
involved in higher cognitive/social functions in both human and mice (DeVito, Lykken 
et al. 2010, Miller, Duka et al. 2012). In contrast, brainstem is mainly composed of 
white matter and it is more devoted to basic function.  
 
As expected, real-time PCR revealed that the percentage of Mbp mRNA was 
significantly reduced in Mbp+/- compared with wild-type mice in both PFC and in 
brainstem at 3 and 6 months (PFC: 3 months p = 0.007, 6 months p = 0.02, Mann-
Whitney; brainstem: 3 months p =0.002, 6 months p = 0.001; Mann-Whitney; wild-type 





expression level anymore. In fact, the percentage of Mbp mRNA was not strictly 
significantly reduced in Mbp+/- vs. wild-type (PFC: p = 0.08, Mann-Whitney; 
brainstem: p = 0.1, Mann-Whitney; wild-type n=4, Mbp+/- n=4 Fig. 7 C, G). 
Independently of the genotype, Mbp expression tends to increase upon ageing in PFC 
(Mbp: p = 0.03, two-way ANOVA; p = 0.08, Jonckheere Terpstra test; wild-type n=4, 
Mbp+/- n=4 per time point;Fig. 7D), but not in the brainstem (Mbp: p = 0.13, two-way 
ANOVA; p = 0.52, Jonckheere Terpstra test; wild-type n=4, Mbp+/- n=4 per time point; 
Fig 7 H). This could be caused by a homeostatic response of the PFC to a general 
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Figure 7: Quantification of Mbp mRNA. Percentage  of Mbp mRNA, normalised to 
18s mRNA in PFC(A-D) and brainstem (E-H) at 3 months (A, E), 6 months (B,F), 20 
months (C, G) of age. The data are expressed in percentage of the average wild-type 
SEM; Mbp+/- n=4, wild-type n=4, Mann-Whitney test. Lifespan amount of Mbp 
mRNA, normalised to 18s mRNA, in PFC(D) and brainstem (H). The data are 
expressed in arbitrary unit (AU)SEM; Mbp+/- n=4, wild-type n=4, two-way ANOVA.  
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MBP undergoes a peculiar translational process, so protein quantification via western 
blot was required to confirm whether the mRNA level was representative of the protein 
level.  
Indeed, at 3 and 6 months Mbp+/- mice expressed ~50% of the MBP amount present in 
wild-type. This held true for both PFC (3 months, p = 0.03, Mann-Whitney; 6 months, p 
= 0.01, Mann-Whitney; wild-type n=4, Mbp+/- n=4; Fig. 8 A, B) and brainstem (3 
months, p = 0.007, Mann-Whitney; 6 months, p = 0.03, Mann-Whitney; wild-type n=4, 
Mbp+/- n=4; Fig. 8 E, F). Unexpectedly, at 18 months we observed a discrepancy 
between the protein level and the mRNA data. In the brainstem,the amount of MBP 
protein was almost comparable between genotypes (Mann-Whitney, p = 0.2, wild-type 
n=4, Mbp+/- n=4; Fig. 8 G), whereas it was drastically reduced (<50%) in the PFC of 
Mbp +/- vs wild-type (Mann-Whitney, p = 0.03; wild-type n=4, Mbp+/- n=4, Fig. 8 C). 
Thus, it appears that, upon ageing, PFC and brainstem respond differently to alteration 
in MBP gene-dosage.   
 
Independently of the genotype, MBP protein in the PFC increased during adulthood and 
drastically decreased upon ageing (p<0.0001, two-way ANOVA, wild-type n=4, 
Mbp+/- n=4 per time point Fig. 8 D). In the brainstem the highest expression of MBP 
was detected at 3 months and the amount of protein gradually decreased upon ageing 
(p<0.0001, two-way ANOVA, wild-type n=4, Mbp+/- n=4 per time point, Fig. 8 H). In 
summary, MBP expression data and the respective protein quantification suggest a 







































































































































































































































Figure 8: Quantification of MBP protein. Percentage to average wild-type of MBP protein, 
normalised to α-tubulin, in PFC(A-D) and brainstem (E-H) at 3 months (A, E), 6 months (B,F), 
20 months (C, G) of age. The data are expressed in percentage of the average wild-type SEM; 
Mbp+/- n=4, wild-type n=4, Mann-Whitney test. Lifespan amount of MBPprotein, normalised to 
α-tubulin, in PFC(D) and brainstem (H). The data are expressed in arbitrary unit (AU)SEM; 
Mbp+/- n=4, wild-type n=4, two-way ANOVA. The graphs are accompanied by the respective 
blot.  
3 mo  20 mo 6 mo 
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4.2.The lack of one allele coding for MBP does not have drastic effects on the 
expression of other myelin-related molecules and on oligodendrocyte number 
To have a preliminary estimation of major effects of MBP reduction on oligodendrocyte 
number, we quantified Plp and Cnp mRNA. It is worth mentioning that also Plp and 
Cnp mRNAsare reduced in post-mortem brain of schizophrenia patients (Table A – 
appendix) (Hakak, Walker et al. 2001, Tkachev, Mimmack et al. 2003). In both PFC 
and brainstem, the percentage of Plp was generally comparable between genotypes (p 
>0.05, Mann-Whitney, wild-type n=4, Mbp+/- n=4 per time point; Fig. 9A-C, E, G). 
The only exception was an isolated reduction in the brainstem of 6 months in Mbp+/- 
mice compared with wild-type (p = 0.03, Mann-Whitney, wild-type n=4, Mbp+/- n=4; 
Fig. 9F). The percentage of Cnp mRNA was totally comparable between genotypes, in 
both PFC (p >0.05, Mann-Whitney, wild-type n=4, Mbp+/- n=4 per time point; Fig. 
10A-C) and brainstem (p>0.05, Mann-Whitney, wild-type n=4, Mbp+/- n=4 per time 
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Figure 9: Quantification of Plp mRNA. Percentage  of Plp mRNA, normalised to 18s mRNA 
in PFC (A-D) and brainstem (E-H) at 3 months (A, E), 6 months (B,F), 20 months (C, G) of age. 
The data are expressed in percentage of the average wild-type SEM; Mbp+/- n=4, wild-type 
n=4, Mann-Whitney test. Lifespan amount of Plp mRNA, normalised to 18s mRNA, in PFC (D) 
and brainstem (H). The data are expressed in arbitrary unit (AU)SEM; Mbp+/- n=4, wild-type 



















Independently of the genotype, the amount of Plp mRNA in the PFC tend to increase 
upon ageing (p = 0.08, two-way ANOVA; p = 0.02, Jonckheere Terpstra test; wild-type 
n=4, Mbp+/- n=4 per time point; Fig. 9D). No trend was detected in the brainstem (p = 
0.8, two-way ANOVA; p = 0.8, Jonckheere Terpstra test; wild-type n=4, Mbp+/- n=4 
per time point, Fig. 9H).  
Cnp mRNA was not affected by ageing in either in the PCF (p = 0.5, two-way 
ANOVA; p = 0.3, Jonckheere Terpstra test; wild-type n=4, Mbp+/- n=4 per time point; 
Fig. 10D) or in the brainstem (p = 0.4, two-way ANOVA; p = 0.08, Jonckheere Terpstra 
test; wild-type n=4, Mbp+/- n=4 per time point; Fig. 10H). At the protein level, the 
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Figure 10: Quantification of Cnp mRNA. Percentage  of Cnp mRNA, normalised to 18s 
mRNA in PFC (A-D) and brainstem (E-H) at 3 months (A, E), 6 months (B,F), 20 months (C, 
G) of age. The data are expressed in percentage of the average wild-type SEM; Mbp+/- n=4, 
wild-type n=4, Mann-Whitney test. Lifespan amount of Cnp mRNA, normalised to 18s mRNA, 
in PFC (D) and brainstem (H). The data are expressed in arbitrary unit (AU)SEM; Mbp+/- 
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mild reduction in the brainstem of 3-month old Mbp+/- vs. wild-type (p=0.03, Mann-
Whitney, wild-type n=4, Mbp+/- n=4; Fig.11D).  
The percentage of CNP protein was generally unchanged in Mbp+/- (p >0.05, Mann-
Whitney, wild-type n=4, Mbp+/- n=4 per time point; Fig. 12A, B, D-F), but it is worth 
mentioning that at 20 months the percentage of CNP was visibly reduced in the PFC of 
Mbp+/- vs. wild-type. Yet this reduction did not reach statistical significance (p=0.06, 
Mann-Whitney, wild-type n=4, Mbp+/- n=4; Fig. 12C). Thus, the reduction of MBP 
seems not to have any major effect on the number of oligodendrocytes. Moreover, Plp 
mRNA, as much as Mbp mRNA, increased upon ageing in the PFC and not in the 
brainstem. This suggests an area-specific gene expression regulation for members of the 
compact myelin. MBP diminishment affects only marginally the amount of CNP and 
































































































































































Figure 11: Quantification of PLP protein. Percentage to average wild-type of PLP 
protein, normalised to α-tubulin, in PFC(A-C) and brainstem (D-F) at 3 months (A, 
D), 6 months (B,E), 20 months (C, F) of age. The data are expressed in percentage 
to average wild-type SEM; Mbp+/- n=4, wild-type n=4, Mann-Whitney test. The 
graphs are accompanied by the respective blots.  
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Figure 12: Quantification of CNP protein. Percentage to average wild-type of 
CNP protein, normalised to α-tubulin, in PFC(A-C) and brainstem (D-F) at 3 
months (A, D), 6 months (B,E), 20 months (C, F) of age. The data are expressed 
in percentage to average wild-type SEM; Mbp+/- n=4, wild-type n=4, Mann-
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4.3.Mbp+/- showed alteration of white matter tracts   
Several studies with conventional and non-conventional Magnetic Resonance Imaging 
(MRI) showed white matter anomalies in schizophrenia patients (section 2.4.2). To 
understand whether and to which extent MBP reduction contributes to alteration 
detected via in imaging, we ran MRI on Mbp+/- vs. wild-type animals in collaboration 
with Prof. Boretius.  
 
Three-month and 6-month old animals did not drastically differ from each other with respect to 
expression data. Since we expected them to be comparable also in MRI, we decided to exclude 
3-month old animals from MRI measurements and to focus on mature (6-month old) and senior 
(18-month old) mice.  
 
In collaboration with Prof. Boretius (Klinik für Radiologie und Neuroradiologie, 
Universitätsklinikum Schleswig-Holstein, Campus Kiel) we ran a comprehensive 
characterization of Mbp+/- vs. wild-type mice via MRI. 
 
Volumetric analysis on Mbp+/- vs. wild-type brains did not reveal any significant 
difference (Table 3). A qualitative inspection of T2-wighted images pinpointed a minor 
thinning of the corpus callosum, a general reduction of the white-to-grey matter contrast 
and a mild alteration in the contrast of cerebellum white matter in 6-month and 18-





















Crbl WM Crbl WM 
CC 
A B 
Figure 13: Sagital section from T2-wighted images. Representative panel showing the 
thinning in the corpus callosum (CC) in Mbp+/- compared with wild-type at 6 months (A) 
and 18 months (B). A mild contrast difference can be observed also in the cerebellar white 
matter (Crbl WM).  
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prominent upon ageing (Fig. 13). Thus, the reduction in MBP does not have a major 
impact on total brain and ventricle size, but specifically affects the corpus callosum. 
Such effect seems to worsen upon ageing. To understand whether the changes in the 
corpus callosum were caused by myelin and fibre alteration, we performed 
Magnetisation Transfer (MT) imaging.  
 
MT imaging of the corpus callosum revealed ~4% reduction in Magnetisation Transfer 
Ratio (MTR), ~20% reduction in Magnetisation Transfer (MT) and ~10% increase in 
T1 in Mbp+/- vs. wild-type (Table 3), at both 6 months and 18 months. This suggested 
that Mbp+/- mice presented mild anomalies in the myelinated fibres of the corpus 
callosum.  
 
Alteration in myelin sheath favours a more disorganised motion of water molecules in 
the brain tissue. The directionality of the movement of water molecules can be 
measured via DTI. To confirm MT data, we imaged the corpus callosum also via DTI. 
However DTI did not mirror the MT data and we could not detect any genotype effect 
on any of the DTI parameters (Table 3).  
 
Independently of the genotype, we observed that MTR and MT mildly increased upon 
ageing (Table 3). Moreover, we observed a general age effect on the parameters 
measured via DTI, i.e. mild increase in Fractional Anisotropy (FA) and a minor 
decrease of Axial Diffusivity (AD), Radial Diffusivity (RD) and Apparent Diffusion 
Coefficient (ADC) upon ageing (Table 3).  
 
4.4.The rostral corpus callosum in Mbp+/- showed a trend in reduction of myelin 
thickness   
T2-weighted images and the MT imaging suggested mild abnormalities in the callosal 
fibres of Mbp+/-, but DTI did not show any genotype-related difference. Moreover, 
visual inspection of fibre staining in the corpus callosum of 18-month old animals did 
not reveal any major genotype-related difference (Fig. 14 1vs.2 and 3vs.4). 
To explain the controversial MRI readouts and to clarify whether there was a real 
alteration in myelin ultrastructure in the corpus callosum, we ran conventional Electron 
Microscopy (EM) in collaboration with Dr. Möbius (Department of Neurogenetics, EM 





Due to the MBP expression data we gathered, we gave priority to the analysis on 18-
month old Mbp+/- vs. wild-type (3 animals per groups). The percentage of non-
myelinated axons (Fig. 14A) and the size of the inner tongue (t-ratio, Fig. 14B) were 
comparable between genotypes. Both Mbp+/- and wild-type mice showed occasional 
widening of the innermost myelin growth zone (t-ratio). This event appeared to be 
slightly more frequent in Mbp+/-, but the difference did not reach statistical significance 
(p=0.24, t test, Mbp+/- n=3, wild-type n=3; Fig. 14C). The quantification of myelin 
thickness (g-ratio) pinpointed a thinning the myelin sheath in Mbp+/- animals compared 
to wild-type (p=0.051, t test, Mbp+/- n=3, wild-type n=3; Fig. 14E, F). This phenotype 
seemed to be affecting mainly axons with a diameter <0.6µm (p=0.005, t test, Mbp+/- 
n=3, wild-type n=3; Fig. 15 A, B), without any effect on the axons with a diameter 
>0.6µm (p>0.05, t test, Mbp+/- n=3, wild-type n=3; Fig. 15 C). It is important to note 
that we detected a highly significant inter-individual variability in the parameters we 
quantified. This is perfectly in line with the normal physiological variability among 
animals. On the other hand, this could make our analysis statistically underpowered for 




Table 3. Magnetic Resonance Imaging results 
The data are expressed in 
mean of Mbp+/- (n =12-17 ) 

































































































































Figure 14: Analysis of myelin ultrastructure. Representative staining for MBP and PLP in the rostral 
corpus callosum of Mbp+/- vs. Wild-type mice (panel 1-4). Representative EM micrograph of Mbp+/- 
vs. wild-type (panel 5,6; magnification 12000X, scale bar 1000nm). Quantification of non-myelinated 
axons (A), inner tongue size (B), frequency of inner tongue enlargement (C), axon diameter (D), 
myelin thickness (E,F). Referring to F´, g-ratio has been calculated as A/[A+(M-T)]; t-ratio has been 
calculated as A/T. The data in the bar graphs are expressed as meanSEM, Mbp+/-  n=3, wild-type 









































































































p = 0.005 
A 
Figure 15: Analysis of myelin thickness in axon subgroups. 
Myelin thickness in small diameter axons (A, B) and bigger 
diameter axons (C). The data in the bar graphs are expressed as 
meanSEM Mbp+/- n=3, wild-type n=3. Statistical significance was 

















































In summary, ultrastructural analyses of myelin in the rostral corpus callosum support 
MT readouts and suggest that the contrast alteration in T2-weighted images could be 

















































































































Figure 16: Inter-individual variability in the parameter 
measured via EM. Comparison among each single mouse in 
relation to myelin thickness (A), axon diameter (B), inner tongue 
size (C) and percentage of non-myelinated axons (D). The data are 
expressed as meanSEM and the statistical significance was 
estimated via one-way ANOVA.  
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4.5.Mbp+/- showed alteration of cortical and callosal metabolism   
In parallel to morphological changes, alteration in brain metabolism and 
neurotransmitters is also documented in schizophrenia patients (Port and Agarwal 2011, 
Kraguljac, Reid et al. 2012, Rowland, Kontson et al. 2013). Thus we wondered if the 
reduction in MBP could cause any of these changes. Metabolic data could also help to 
interpret the discordant results in MRI.  
In collaboration with Prof. Boretius (Klinik für Radiologie und Neuroradiologie, 
Universitätsklinikum Schleswig-Holstein, Campus Kiel) we ran 
1
NMR Spectroscopy in 
cortex, corpus callosum and hippocampus. Cortex and corpus callosum were chosen 
because they showed genotype-related differences in all the analyses reported until now. 
The hippocampus was also included because of the several evidences of its metabolic 
alteration in schizophrenia(Port and Agarwal 2011). In 6-month old mice we observed 
increase in neurotransmitters GABA (+13%) and Glutamate (+ 7%), accompanied by an 
increase in Taurine (+6%) in the cortex of Mbp+/- compared with wild-type. We 
detected a subtle increase of myo-Inositol (+3%) both in the cortex and in the corpus 
callosum of Mbp+/- compared with wild-type, which could suggest the presence of a 
mild gliosis (Table 4). Upon ageing (18 month) some of these metabolic alterations 
became even more pronounced. In the cortex of Mbp+/- mice we observed an increase 
in Glutamate (+11%), in myo-Inositol (+10%), in Taurine (+13%) and in tCreatine 
(+10%) (Table 4), that could give further evidences for glia activation. In the corpus 
callosum we detected increase of myo-Inositol (+12%) and increase of Taurine (+7%) 
(Table 4). No significant genotype effects were detected in the hippocampus.   
 
Independently of the genotype, an effect of ageing on brain metabolites was detected: an 
increase of glutamine in cortex, corpus callosum and hippocampus; a reduction of 
glutamate, GABA, Taurine in the cortex; a trend in the increase of myo-Inositol, an 
increase of choline and tCreatine in the corpus callosum; an increase of tCreatine in the 
hippocampus (Table 4).  
Taken together the data suggest that the reduction in MBP leads to alteration in cortical 




























































Table 4. Magnetic Resonance Spectroscopy 
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4.6.MBP reduction led to an increase in the number of Iba1+ cells in the rostral 
corpus callosum of Mbp+/- compared with wild-type 
The metabolic alteration detected via 
1
NMR spectroscopy suggested glial activation in 
the cortex and in the corpus callosum of Mbp+/- mice compared with wild-type 
(p=0.02, two-way ANOVA, Mbp+/- n=10-18, wild-type n=14-15; Fig. 17 A). myo-
Inositol increase is often a signature of gliosis (Taylor, Selvaraj et al. 2009)and since we 
confirmed a mild ultrastructural alteration of myelin in Mbp+/-, we wondered whether 
the increase in myo-Inositol was associated with changes in microglia number. 
We stained brain sections of 14-month old animals (time point in between the two 
1
NMR spectroscopy measurements) for the microglia marker ionized calcium-binding 
adapter molecule 1 (IBA1) and we detected almost 30% increase of Iba1+ cells in the 
rostral corpus callosum of Mbp+/- compared with wild-type (p = 0.005, two-tailed t 




















































Figure 17: Signs of gliosis in the corpus callosum of Mbp+/- mice. Increase in myo-
inositol in the corpus callosum of Mbp+/- vs. wild-type (A). The data are expressed as 
mean valuesSEM; Mbp+/- n=10-18, wild-type n=14-15. Statistical significance was 
estimated via two-way ANOVA. Iba1+ cells quantification (B) and representative images 
of Iba1 staining (Iba1 in red, DAPI in blue). The data are expressed as mean valuesSEM; 





which affects cortical and callosal metabolism, leading to a prominent increase in 
microglia.  
 
4.7.Mbp+/- mice specifically showed a decrease in pre-pulse inhibition of startle 
response and in acoustic startle response 
Our ultimate goal was to explore the role of MBP reduction in schizophrenia 
symptomatology (see section 2.4.1). Consequently, we screened several behavioural 
domains in young (3-month to 8-month old) animals and senior (>17-month old) 
animals.  
To exclude any gross alteration of basic behaviour, we first characterise motor and 
sensory functions. This was the necessary requirement for us to proceed with the 
analysis of more complex behavioural domains afterwards. Abnormal basic function 
would invalidate any further behavioural test. As expected, Mbp+/- vs. wild-type mice 
showed comparable and normal basic sensory and motor functions (Table 5).  
Anxiety-like behaviour, tested in elevated plus maze and open field, was comparable 
between Mbp+/- and wild-type mice (Table 5). The negative symptoms of 
schizophrenia include depressive-like behaviour and social withdrawal, so we explore 
these behavioural domains in our animals.  Signs of anhedonia, compulsive behaviour 
or abnormal house behaviour were not detectable (Table 5). Sociability was also 
comparable between groups. Cognitive impairment is also reported in schizophrenia 
patients(Walker, Kestler et al. 2004, Aaron T. Beck 2011), so we screened learning and 
memory abilities in Mbp+/- compared with wild-type. Social memory and learning 
abilities were comparable between genotypes (Table 5). Soft-neurological signs are 
common in schizophrenia patients and one could speculate that they could be associated 
with mild myelin alteration.  
We set up a behavioural test to quantify fine motor functions and we called it “Grasping 
test”. It derived from the combination of “paw preference test”(Collins 1975, Ribeiro, 
Eales et al. 2013) with the reaching chamber test to check for grasping abilities(Qian, 
Lei et al. 2010). However, even in this domain, Mbp+/- and wild-type were comparable.  
Schizophrenia patients show deficits in screening out irrelevant environmental stimuli, 
i.e. sensorimotor gating deficit. This is thought to lead to the cognitive fragmentation 
often reported in patients(Braff, Stone et al. 1978, Braff, Geyer et al. 2001). Since 
myelin is crucial for the proper synchronisation among different brain areas, we 
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wondered whether such subtle abnormalities in myelin could be causative of 
sensorimotor gating deficits.  
We explored this behavioural domain via pre-pulse inhibition (PPI) of startle reflex.  
Both mature and senior Mbp+/- mice showed a reduction in PPI when compared with 
wild-type (p = 0.01, repeated measures two-way ANOVA, Fig. 18A;p = 0.08, repeated 
measures two-way ANOVA,Fig. 18C). Mature Mbp+/- showed a reduction trend in 
baseline acoustic startle response when compared with wild-type; however the 
difference did not reach statistical significance (p = 0.2, Mann-Whitney test; Fig. 18B). 
Upon ageing, senior Mbp+/- clearly manifested a reduction in baseline acoustic startle 
response when compared with wild-type mice (p = 0.01, Mann-Whitney test; Fig. 18D). 
Body weight was comparable between groups (data not shown). 
Taken together, the reduction of MBP has a clear and specific effect on a behavioural 
domain involved in sensorimotor gating functions; this domain is clearly affected in 
































































































































Figure 18: Deficit in 
sensorimotor gating in Mbp+/- 
detected via PPI and reduction 
in baseline acoustic startle 
response. Significant reduction in 
PPI in both young (A) and senior 
(C) Mbp+/- mice (black) when 
compared to wild-type (white). 
The data are expressed as mean 
valuesSEM; Mbp+/- n=34, wild-
type n=22. Statistical significance 
was estimated via repeated 
measure two-way ANOVA. 
Baseline of the acoustic startle 
response in both young (B) and 
senior (D) Mbp+/- vs. wild-type 
mice. The data are expressed as 
mean valuesSEM; Mbp+/- n=34, 
wild-type n=22. Statistical 
significance was estimated via 










The aim of my PhD project was to explore the consequences of myelin-related 
abnormalities in schizophrenia. Whether myelin alteration is cause or consequence of 
the pathology it is not clear, but several studies indicate a major role of the myelin-
related pathway in the course of the disease (Goudriaan, de Leeuw et al. 2014, 
Haroutunian, Katsel et al. 2014). The molecular mechanism leading to myelin 
anomalies in schizophrenia is not defined; however post-mortem studies revealed a 
general reduction of several myelin-related proteins (and mRNA), like MBP, suggesting 
a contribution of oligodendrocyte and myelin to the pathology (Hakak, Walker et al. 
2001, Flynn, Lang et al. 2003, Dracheva, Davis et al. 2006). 
As major protein of the CNS compact myelin, MBP is one of the most intriguing 
candidates to study. Yet nobody, until now, extensively analysed the meaning of MBP 
reduction in the context of schizophrenia.  
We extensively characterised a largely unexplored mouse model, heterozygousshiverer 
(here called Mbp+/-). Specifically, we wondered whether the lack of one Mbp allele 
(Barbarese, Nielson et al. 1983) caused any schizophrenia-like phenotype that might 
have been overlooked in the past.  
From post-mortem studies it is not possible to infer at which stages of the disease the 
changes in MBP expression appeared. Moreover, myelin is a very stable structure and 
the altered expression of its structural components in animal models has often disclosed 
a phenotype only upon ageing (Aggarwal, Yurlova et al. 2011, Hagemeyer, Goebbels et 
al. 2012). Thus, we broaden our analysis and we explored the effect of MBP reduction 
in young, mature and senior animals, to understand the consequence of MBP reduction 
at young and older age.  
 
We were able to prove that, indeed, 50% of MBP is detrimental for the CNS and lead to 
subtle, yet pathological, phenotypes. We showed that MBP presents a specific spatio-
temporal expression pattern and its reduction only mildly affects other two important 
myelin proteins, i.e. CNP and PLP, and the oligodendrocyte number. Yet, MBP 
diminishment alters cortical and callosal metabolism and varies fibre structures in the 
corpus callosum, specifically affecting myelin thickness in small calibre axons 





increase microgliosis. These subtle biological phenomena induce and orchestrate the 
abnormal sensorimotor gating and the worsening of the startle response to acoustic 
stimuli.  
 
The reduction of MBP, at both protein and mRNA level, was the necessary prerequisite 
for my PhD project. Moreover, it was necessary to estimate the impact of MBP 
reduction on the other most abundant myelin-related mRNA and proteins of the CNS, as 
a proxy of oligodendrocyte number and indication of potential more prominent myelin 
damage.  
Barbarese et al. in the early eighties showed a ~50% reduction of MBP (mRNA and 
protein) in total brain and purified myelin of 15-day and 90-day Mbp+/- mice compared 
with wild-type (Barbarese, Nielson et al. 1983). Besides the reduction of MBP, no other 
myelin phenotype was detected (Barbarese, Nielson et al. 1983). 
In contrast to Barbarese’s data, Cammer et al reported that the reduction in MBP in 
Mbp+/- mice was also accompanied by a mild diminishment of PLP (Cammer 1982). 
These controversial observations suffered also from other two main limitations: 
quantifications were run (1) on the whole brain and (2) at one single time point.  
Thus, life-span observation of MBP, PLP, and CNP expression in subregions of the 
Mbp +/- mouse brain was missing.  
We explored the effect of missing one Mbp allele (1) at 3 time points (2) in two specific 
brain areas (PFC and brainstem). The lifespan of mice varies between 1.3 to 3 years, 
depending on the mouse strain (Comfort 1959), so we selected to run mRNA and 
protein quantification on young (3 months), mature (6 months) and senior (>17 months) 
animals. The selection of PFC and brainstem ensured an estimation of the MBP 
expression in grey vs. white matter and, in parallel, in brain area highly affected in 
schizophrenia (Perlstein, Carter et al. 2001) and related to high cognitive functions 
(PFC) in contrast to an area mainly devoted to more basic and vegetative functions 
(brainstem).  
The ~50% reduction of MBP expression in adult Mbp+/- vs. wild-type was confirmed in 
both PFC and brainstem and the mild decrease in PLP protein detected by Cammer et al 
in Mbp+/- was also partially confirmed (in the brainstem at 3 months). Our results 
added also a new insight into MBP expression, showing that, upon ageing, PFC 
becomes much more susceptible than brainstem to the lack of one Mbp allele. Already 
in 1975 it was showed that MBP was strongly reduced in aged human post-mortem 
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PFC(Ansari and Loch 1975), suggesting a major effect of ageing on frontal 
myelination. However no other studies reported such major reduction in MBP protein in 
Mbp+/- mice, even in presence of an almost physiological amount of Mbp mRNA.  
Studies on developmental process highlighted a specific “spatiotemporal pattern” of 
myelination and MBP expression, both in rodents and primates. Specifically, 
myelination process initiates in the caudal part of the brain, proceeds towards the 
temporal lobe and ends in the frontal areas (Delassalle, Zalc et al. 1981, Kanfer, Parenty 
et al. 1989, Lebel, Gee et al. 2012, Miller, Duka et al. 2012). Moreover, it has been 
observed that human myelination in the frontal areas of the brain follows a bell-shape 
trend, increasing to a maximum peak in late-adulthood and decreasing during the 
process of ageing (Haroutunian, Katsel et al. 2014). Considering this extreme reduction 
of MBP protein in the PFC, one could speculate that PFC in Mbp+/- mice ages faster 
than in wild-type. This hypothesis could be interesting in the context of schizophrenia, 
which has been also proposed to be a syndrome of accelerated ageing (Kirkpatrick, 
Messias et al. 2008). The hypothetical accelerated PFC ageing could also explain the 
reduction trend in CNP protein, exclusively detected in 20-month old Mbp+/- PFC. On 
the one hand, such reduction could be a first sign of an approaching oligodendrocyte-
related pathology, often detected in ageing brain (Weiss, Hammer et al. 2000). On the 
other hand, since CNP has also been suggested to orchestrate myelin compaction almost 
in antagonism to MBP (Snaidero, Mobius et al. 2014), it is possible that its reduction 
might be a homeostatic compensation for the more prominent (<50%) MBP 
diminishment. 
These results raise the question on how different brain areas regulate myelination at 
different period in life. However, my data cannot give a clear and conclusive answer to 
this question. It appears that, upon ageing, the higher amount of MbpmRNA, does not 
correlate with the amount of MBP protein. This could be caused by three general 
mechanisms: (1) the half-life of the Mbp mRNA diminishes in the PFC upon ageing, so 
even an increase in Mbp transcription is not able to make up for the high rate of mRNA 
degradation; (2) the translational machinery for MBP is differently regulated upon 
ageing in PFC compared to brainstem; (3) the protein stability is reduced and MBP is 
more prone to degradation. Further studies are required to give a more detailed 






The molecular phenotype of Mbp+/- mice was associated to a quite multifaceted 
combination of structural and metabolic alterations, detected via structural MRI and 
MRS. We limited the MRI and MRS measurements to two time points (6 months and 
>17 months), since our expression data did not reveal major differences between 3 
months and 6 months animals.  
It has been consistently showed that schizophrenia patients often suffer from a reduction 
in brain volume and ventricular enlargement, mainly due to grey matter loss (Gur, 
Keshavan et al. 2007, Sun, Maller et al. 2009). However, in our mouse model we failed 
to detect any major brain atrophy or ventricular enlargement in Mbp+/- mice compared 
with wild-type. We cannot completely exclude changes in volume in specific brain 
regions, but we can confidently state that MBP reduction does not have a major impact 
on general grey matter volume.  
On the other hand we observed alteration in white matter of Mbp+/- mice. In the context 
of conventional structural MRI, T2-weighted images can give an overview on general 
alteration in the tissue. Among them, oedema, myelin alteration, tissue damage, gliosis 
and changes in lipid composition could be detected (Symms, Jager et al. 2004, 
Barkovich 2005, Tanaka, Iwasaki et al. 2012). Previous studies did not reveal any 
difference in T2-weighted images in Mbp+/- vs. wild-type mice (Martin, Hiltner et al. 
2006), whereas we unequivocally observed that Mbp+/- mice present a thinning of the 
corpus callosum, associated to a reduction of grey matter to white matter contrast. It is 
noteworthy that a thinning of the corpus callosum has also been reported in 
schizophrenia patients (Balevich, Haznedar et al. 2015). 
The corpus callosum is one of the most highly myelinated tracts of the brain, so we 
speculated that the reduction of MBP had indeed an effect on myelin structure. However 
T2-weighted images contrast alterations could not be univocally attributed to myelin 
damages (Symms, Jager et al. 2004, Barkovich 2005, Tanaka, Iwasaki et al. 2012). 
Consequently, we proceeded with complementary non-conventional MRI techniques, 
with focus on myelin and fibre bundles, namely MT and DTI. MT technique relies on 
the property of a tissue, e.g. myelin, to exchange magnetisation from its 
macromolecular proton pool to the protons of biological liquids and indirectly estimates 
the amount of water protons associated with macromolecules(Henkelman, Stanisz et al. 
2001). MT is much more sensitive than conventional MRI in detecting ultrastructural 
changes in the brain tissue and several studies have showed a clear correlation between 
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MT parameters and myelin content (Grossman, Gomori et al. 1994, Benedetti, Charil et 
al. 2006). The genotype-dependent reduction in Magnetisation Transfer Ratio (MTR), in 
Magnetisation Transfer (MT) saturation and the increase in T1 strongly suggested 
myelin alterations.  
Surprisingly, DTI parameters were not affected by the reduction in MBP. DTI in the 
brain measures the diffusivity of water molecules along the axons, giving an estimation 
of both perpendicular and transversal water diffusion in respect to axons (Basser, 
Mattiello et al. 1994, Le Bihan, Mangin et al. 2001). In healthy axons, the water 
particles are restricted to one preferential direction (anisotropic movement), whereas a 
damaged axon allows a more disordered and unrestricted movement of water molecules 
(less anisotropic movement) (Basser, Mattiello et al. 1994, Le Bihan, Mangin et al. 
2001). Intuitively, in case of myelin disruption the motion of water molecules would be 
less restricted (Stikov, Campbell et al. 2015).  
Indeed, animal models of de-myelination show reduction in Fractional Anisotropy (FA) 
and an increase in radial diffusivity (RD), as indication of less organised motion of 
water molecules (Fatemi, Folsom et al. 2009). However, this is not observed in our 
model.  
To understand the incongruities between MRI data we proceed with analysis of myelin 
ultrastructure of the corpus callosum of Mbp+/- vs. wild-type mice.  
Our ultrastructural analysis of the rostral corpus callosum in senior mice suggests a 
trend in reduction of myelin thickness, especially in small calibre axons. This finding is 
in line with the studies on myelin development and on model of demyelination. Small-
calibre axons are normally myelinated after big-diameter axons (Remahl and 
Hildebrand 1982, Hildebrand, Remahl et al. 1993) and in mouse models of 
demyelination/hypo-myelination small-calibre axons are often the most affected ones 
(Umemori, Sato et al. 1994, Klugmann, Schwab et al. 1997, He, Dupree et al. 2007). 
One could speculate that, upon reduction of myelin component, the CNS might need to 
adapt and give priority axons subtypes over others.  
It is worth mentioning that a bigger sample size and the analysis on 6-month old 
animals would be required to complement the EM data (note the significant inter 
individual variability); however, the current results support the MT readouts, suggesting 
mild alteration in Mbp+/- myelin structure.  
Then, if myelin is really altered in Mbp+/-, how can we interpret such “inconsistency” 





generally accompanied by alteration in DTI readouts; however it is not uncommon to 
detect MTR reduction without DTI changes and vice-versa, indicating how these two 
methods are only partially overlapping in the detection of biological substrates 
(Kubicki, Park et al. 2005). One possible explanation would be that MT might be more 
sensitive than DTI to subtle changes that uniquely affect myelin (Kubicki, Park et al. 
2005). Shiverer total knock-out mice miss both alleles for MBP and lack of compact 
myelin in the CNS; however they present an average of 10-15% reduction in FA 
compared to wild-type (Nair, Tanahashi et al. 2005, Tyszka, Readhead et al. 2006). We 
know from the literature that shiverer mice do not have major axonal alteration and it 
has been speculated that the anisotropy is partially preserved by such axonal integrity, 
even if myelin is not compacted (Song, Sun et al. 2002). Since our MRS data suggest 
preservation of neuronal function and density also in Mbp+/- corpus callosum, i.e. 
comparable N-Acetylaspartate (NAA) concentration between groups(Duarte, Do et al. 
2014), one could speculate that Mbp+/- mice do not show any major difference in DTI 
because the axonal tracts are preserved and the myelin abnormalities are too subtle to be 
detected with this method.  
Another explanatory model would be that the preservation of water directionality could 
be ensured by other glial cells surrounding the abnormally myelinated axons(Aung, Mar 
et al. 2013). A difference in the cell composition could also justify the major difference 
in contrast detected in T2-weighted images that could not be explained only by subtle 
alteration in myelin.  
 
Our MRS data are more supportive of the second model. We detected a general increase 
in myo-Inositol in cortex and corpus callosum of Mbp+/- vs. wild-type. Myo-Inositol is 
a precursor in the phosphatidylinositol second messenger system and it is required for 
synthesis of membrane phospholipids (Kim, McGrath et al. 2005). Myo-Inositol is also 
an important osmolyte in glial cells and its increase is generally associated with gliosis 
(Taylor, Selvaraj et al. 2009). We indeed detected gliosis in the rostral corpus callosum 
of Mbp+/- mice, with a 30% increase in Iba1+ positive cells. We did not stain for Iba1+ 
cells in the cortex, but we expect a similar response also in this area.  
Interestingly, increase in microglia and inflammation markers has also been reported in 
schizophrenia patients (Chew, Fusar-Poli et al. 2013, Fillman, Cloonan et al. 2013), 
even if not consistently (Chiappelli, Rowland et al. 2015). 
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The biological meaning of this increase is still obscure. Microglia can secrete cytotoxic 
molecules and it is found to be activated in tissue of patients affected by 
neurodegenerative and white matter disorders (Peferoen, Kipp et al. 2014), but other 
studies also show that microglia is relevant for myelin synthesis, myelination and 
clearance of myelin debris (Hamilton and Rome 1994, Howe, Mayoral et al. 2006, 
Miron, Boyd et al. 2013). From our data it is not possible to draw definitive conclusion. 
The increase of microglia could serve as an homeostatic response to MBP reduction, to 
catch up with the subtle defect in myelination. In this frame, microglia could secrete 
anti-inflammatory cytokines and growth factors to promote myelination(Miron, Boyd et 
al. 2013). Alternatively, the increase in microglia could be a manifestation of an 
inflammatory response due to the abnormalities in myelin ultrastructure. In this case, 
microglia would secrete pro-inflammatory cytokines and reactive oxygen species 
(Miron, Boyd et al. 2013). Further studies are required to clarify the role of the increase 
in microglia in Mbp+/-.  
Myo-Inositol was not the only altered metabolites in the Mbp+/- brain. We also detected 
an increase in Taurine in both corpus callosum and cortex. Taurine is the second most 
abundant metabolite in the brain after glutamate(Bulley and Shen 2010) and its 
transporter is found both in astroglial cells and neurons, especially in glutamatergic 
neurons (Bulley and Shen 2010). Its role in the brain is still unclear, but it seems to 
work as osmolyte and neuroprotective agent, especially in case of glutamate-induced 
excitoxicity (Zwingmann, Leibfritz et al. 2003, Albrecht and Schousboe 2005, Wu and 
Prentice 2010). Taurine is 3-4 fold higher in neonates than in adults (Shivaraj, Marcy et 
al. 2012)and supplementation of taurine to ageing mice was reported to delay the age-
dependent cognitive decline (El Idrissi, Shen et al. 2013).  
Higher level of taurine has been found in plasma and prefrontal cortex white matter of 
medicated schizophrenia patients compared with control (Prabakaran, Swatton et al. 
2004, Samuelsson, Skogh et al. 2013).  
The significantly higher level of taurine in Mbp+/- cortex could be related to the parallel 
increase of glutamate. On the one hand, it could be a compensatory mechanism to 
prevent axonal damage, caused by glutamate-related excitotoxic. On the other hand, the 
increase of glutamate could trigger exosome secretion from oligodendrocyte(Fruhbeis, 





taurine would be a concomitant mechanism to further support axons. However, we 
would need further confirmatory experiments to prove these points. 
The other MRS changes in Mbp+/- mice are localised at cortical level. This is not too 
surprisingly, considering the peculiar regulation of MBP expression in PFC. On top of 
the increase of myo-Inositol and taurine, the cortex of Mbp+/- presented an increase in 
glutamate, GABA and total creatine.  
GABA and glutamate are well-known neurotransmitter in the brain. Elevated cortical 
and white matter glutamate has been reported in early/acute psychosis and in non-
medicated patients (Chiappelli, Hong et al. 2015), moreover increase of GABA has also 
been detected in the prefrontal cortex of drug-naive patients (Port and Agarwal 2011). 
Glutamate excitotoxicity is supposed to be responsible for permanent brain damage 
(Port and Agarwal 2011), but from our data we cannot extrapolate whether we have 
excitotoxic process ongoing. On the other hand, it has been documented that the release 
of glutamate could also induce OPC proliferation and MBP translation (Barres and Raff 
1993, Wake, Lee et al. 2011). As already mentioned, pools of OPCs survive in the adult 
brain as reservoir of precursor to produce oligodendrocytes. Considering the almost 
70% reduction in MBP and the reduction trend in CNP, the cortex of Mbp+/- could be 
in need of myelin and myelinating cells. The increase in glutamate could stimulate the 
proliferation of OPCs and MBP translation (Wake, Lee et al. 2011); the parallel increase 
in myo-Inositol (microglia) could promote differentiation (Miron, Boyd et al. 2013). 
Last but not least, glutamate increase could be a footprint of increased neural activity, 
which could promote myelination (Petersen and Monk 2015) or 
The increase in total creatine is in line with both these speculations. In fact creatine is a 
shuttle of high-energy phosphate for ATP production that could be involved in both 
processes (Brosnan and Brosnan 2007). Further experiments are definitely required to 
explain the metabolic alteration in Mbp+/- mice.  
Independently of the genotype, another interesting finding emerged from the MRI and 
MRS data. MT, MTR, FA are higher in “senior”  vs. “mature” animals; moreover, total 
brain volume and NAA are unchanged and white matter volume in the corpus callosum 
is bigger in “senior” mice vs. “mature” mice. As mentioned, MTR and FA reduce in 
case of pathology, but also in case of physiological ageing; until adult midlife, white 
matter volume keeps increasing (Benedetti, Charil et al. 2006). On the other hand 
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glutamate, GABA and taurine are significantly lower in “senior” animals compared to 
“mature”  and a reduction of glutamate and GABA is generally detected upon ageing, as 
an indication of the reduction in synaptic functions, reduction of creatine (Duarte, Do et 
al. 2014). 
Thus, this data suggest that the ageing process has most likely just started in “senior” 
animals and the first change comes from alteration of brain metabolism, specifically at 
neurotransmitter level.  
The ultimate aim of my PhD research was then to explore the consequences of 
morphologic and metabolic alteration, induced by MBP reduction, on behavioural 
phenotypes.   
The necessary prerequisite for the translational validity of this mouse model was to 
show that Mbp+/- mice did not present any gross basic functional alteration. Impairment 
in basic functions would have prevented reliable testing of other more complex 
behavioural domains.  
Body weight, locomotion, swimming and basic perceptions (hearing, smell, sight and 
pain perception) were completely comparable in Mbp+/- vs. wild-type. This basic 
comparability between the two groups allowed me to proceed with higher function 
testing.  
The alteration in the corpus callosum and the mild myelin abnormalities gave me a hint 
for setting up a test to evaluate fine motor functions and handedness in Mbp+/- vs. wild-
type. It has been reported that mice missing the corpus callosum show altered paw 
preference (Ribeiro, Eales et al. 2013); moreover, in human, the inter-hemispheric 
connections, mediated by the corpus callosum, are crucial for timing and accuracy of 
motor tasks and motor control and they are important for bimanual and unimanual 
motor skills (Wahl, Lauterbach-Soon et al. 2007, Takeuchi, Oouchida et al. 2012). In 
parallel, since it has been reported that schizophrenia patients manifest subtle 
neurological symptoms (Walther and Strik 2012), I wandered if the subtle abnormality 
in myelin could be the biological base for fine motor function alteration.   
We set up a test to measure these skills in mice, i.e. “grasping test”. This test derives 
from the combination of paw preference test, first described by Collins in 1975 (Collins 
1975), and the skilled reaching test, to quantify grasping abilities (Miklyaeva, 





grasping abilities or paw preference, suggesting that MBP reduction does not play a 
major role in this domain.  
Schizophrenia patients show also cognitive impairment, social withdrawal, depression 
and anxiety (Ross, Margolis et al. 2006) and in mouse model these symptoms have been 
associated with reduction in myelin proteins and alteration in myelin (Liu, Dietz et al. 
2012, Makinodan, Rosen et al. 2012). Consequently, I challenged the animals with 
several different cognitive and social tasks and I quantified the anxiety-like and 
depression-like behaviour. Unexpectedly, I did not detect any difference between the 
two groups, suggesting that MBP reduction does not have striking consequences on 
sociability and memory and it is unlikely to have a major effect on depression-like and 
anxiety-like symptoms in schizophrenia.  
Schizophrenia patients are also characterised by sensorimotor gating deficits, meaning 
that they are not able to properly screen out irrelevant sensory stimuli from the 
environment (Braff and Light 2005, Kumari, Fannon et al. 2008). The sensorimotor 
gating impairment could be causative of sensory overload and cognitive fragmentation, 
typical of schizophrenia patients(Geyer 2006). Interestingly, this deficit has also been 
described in unaffected biological siblings of schizophrenia patients, pointing out a 
genetic contribution to the development of sensorimotor gating impairment (Kumari, 
Das et al. 2005). Both in human and in rodents, sensorimotor gating alteration has been 
correlated to cortical grey matter volume, myelin abnormalities and also to 
inflammatory processes (Fan, Goff et al. 2007, Kumari, Fannon et al. 2008, Takahashi, 
Sakurai et al. 2011). Thus, we wandered whether the reduction in MBP, and the 
consequent morphological and metabolic alteration accompanied by gliosis, led to 
alteration in prepulse inhibition (PPI) of acoustic startle response, a cross-species 
measure for sensorimotor gating. We found a reduction in PPI in Mbp+/- mice 
compared with wild-type, independently of the age.  
PPI is considered to be mediated by the cortico-striato-pallido-thalamic circuitry in both 
mice and human (Kumari, Fannon et al. 2008, Ahmari, Risbrough et al. 2012) and it 
relies on several different signalling pathways.  
One could speculate that mild abnormalities in myelin (especially callosal and cortical 
myelin) led to reduced synchronisation among brain regions. Neurotransmitter (GABA 
and glutamate) misbalances and gliosis could follow and induce the impairment in 
sensorimotor gating, via a general alteration of the neuronal network.  
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The idea of a general “network disturbance disorder” more than a “single pathway 
disease” would also reconcile the different hypotheses of schizophrenia, which involve 
several different molecular pathway (Takahashi, Sakurai et al. 2011). Additionally to 
the PPI deficit, we also detect a reduction of acoustic startle response in “senior” 
Mbp+/- vs. wild-type mice. The primary circuitry of the pure acoustic startle response is 
located in the lower brainstem and it seems to be relatively simple when compared to 
the PPI (Koch 1999). Reduction in baseline startle reactivity has been associated with 
depressive episodes (Kaviani, Gray et al. 2004, Aaron T. Beck 2011). Whether Mbp+/- 
mice show a reduced baseline startle as a first manifestation of depressive-like 
phenotype is not clear and it cannot be concluded from our data. Further analyses are 
required to better understand this behavioural readout.  
In conclusion, our results suggest that the reduction of MBP could be partially causative 
of part of the myelin abnormalities detected in schizophrenia patients, affecting 
primarily the frontal region of the brain. The consequences of myelin alteration could 
have an impact on the synchronisation among various brain regions, leading to 
alteration in neurotransmitters, gliosis and network dysfunctions.  
 
6.TRANSLATIONAL VALIDITY OF THE MODEL AND 
OUTLOOK FOR FUTURE RESEARCH 
The mouse model we characterised was a first attempt to understand the role of MBP 
reduction (and MBP-related abnormalities in myelin) in schizophrenia. Specifically, we 
wanted to define which symptoms/sub-phenotypes could be attributed to the reduction 
of MBP over life. Table 6 summarises the data from Mbp+/- mice and compares them 
with the parallel finding in schizophrenia patients.   
It is worth mentioning that this mouse model has two main limitations: (1) it is a 
conventional knock-out and (2) it allows exploring the consequences of MBP reduction, 
but it does not explain why such variation occurs in schizophrenia patients.  
The first point leads to a major problem in relation to the construct validity of the 
model. We ensure a reduction in MBP expression via removal of one Mbp allele in the 





However, the deletion of Mbp does not resemble the condition of schizophrenia 
patients, which have reduction in Mbp expression in the cortical areas and not Mbp 
mutation/deletion. To overcome this problem and to optimise the validity of the mouse 
model, one possibility would be to reduce MBP expression in cortical areas via 
silencing RNA technology. This would allow a specific spatiotemporal reduction of 
MBP expression that could be more informative for our purposes.  
The second point is more complicated to approach, because the causes of schizophrenia 
are still unclear. Gene, environment and gene-environment interaction are all 
contributing to the development of the pathology, but how (and if) they specifically 
affect MBP expression is not known. However, despite its limitations, the Mbp+/- 
model could be used to shed light on the causes of “myelin-related sub-phenotypes” in 
schizophrenia. 
To study the role of environment per se on “myelin-related sub-phenotype” in 
schizophrenia, one possibility would be to expose wild-type animals to environmental 
stimuli, resembling known risk factors for schizophrenia in human, for instance 
cannabis consumption (Zammit, Allebeck et al. 2002). 
Our Mbp+/- model could then come into play and could be used for comparative 
purposes. In this way, one could have a hint on which environmental conditions are 
likely to lead to MBP reduction and the consequent morphological, metabolic and 
behavioural alteration we detected in Mbp+/- mice.  
To explore the effect of the gene-environment interaction one possibility would be to 
expose wild-type and Mbp+/- animals to environmental stimuli, that are known to alter 
myelination and to be potential risk factors for developing schizophrenia, for instance, 
social isolation (Hoffman 2007, Liu, Dietz et al. 2012, Makinodan, Rosen et al. 2012). 
Via these analyses, one could estimate the susceptibility to an environmental insult of 
animals that aregenetically predisposed to show schizophrenia-like sub-phenotypes 
(Mbp+/- mice) in comparisonwith wild-type.  
In summary, we showed that MBP reduction has indeed subtle, yet pathological, 
consequences and, these consequences resemble several phenotypes detected in 
schizophrenia patients. Consequently, being aware of the limitations of this model, in 
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the context of our translational purposes Mbp+/- mouse couldbe used to study mild 
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Table A. Myelin genes in schizophrenia. 
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8.LIST OF ABBREVIATIONS 
 
Abbreviation Extended name 
AD Axial Diffusivity  
ADC Apparent Diffusion Coefficient  
BBB Blood Brain Barrier  
CALG Galactosylceramidase 
CLDN11 Claudin 11 
CNP 2′:3′-Cyclic nucleotide 3′-phosphodiesterase 
CNS Central Nervous System 
DAPI 4’,6-Diamidino-2-phenylindole  
EM Electron Microscopy  
FA Fractional Anisotropy 
GABA gamma-Aminobutyric acid 
golli genes of oligodendrocytes lineage 
GWAS Genome-Wide Association Studies  
hnRNP Heterogeneous nuclear Ribonucleoprotein  
IBA1 Ionized calcium-Binding Adapter molecule 1 
kif1b Kinesin Family Member 1b 
MAG Myelin Associated Glycoprotein  
MAG Myelin Associated Glycoprotein  
MBP Myelin Basic Protein 
MOBP 
Myelin-associated Oligodendrocyte basic 
protein 
MOG Myelin Oligodendrocyte Glicoprotein 
MPZL1 Myelin Protein Zero 1 
MRI Magnetic Resonance Imaging  
mRNA Messenger RNA 
MRS Magnetic Resonance Spectroscopy  
MT sat Magnetization saturation  
MTR Magnetisation Transfer Ratio  
NAA N-Acetylaspartate 
NG2 Neural/Glial antigen 2 




Olig1 Oligodendrocyte Transcription Factor 1 
Olig2 Oligodendrocyte Transcription Factor 2 
OPCs Oligodendrocyte Precursor Cells 
OR Odds Ratio  
P21-P35 Post-natal day 21-Post-natal day 35  
P23 Post-natal day 23  
PCR Polymerase Chain Reaction 
PDGFR-
aplha 
platelet-derived growth factor receptor -alpha  
PFC Prefrontal Cortex 
PIP2 Phosphatidylinositol 4,5-bisphosphate  
PIP3 phosphatidylinositol-(3,4,5,)-triphosphate  
PLP Proteolipid protein 
PPI Pre-pulse inhibition of startle response  
PTM Post-translational Modification 
QK1 Protein Quacking 1 
RD Radial Diffusivity 
RLR RNA Localisation Region 
RNA Ribonucleic acid 
Sirt2 Sirtuin 2  
SOX10 Sex Determining Region Y)-Box 10 
TE Echo Time 
TR Repetition Time 
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